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ABSTRACT 
 
The purpose of the study was to explore and describe the perceptions of the HIV 
positive pregnant mothers regarding the PMTCT Option B+ programme in order to 
identify and describe gaps; and also help the Swaziland government address these 
gaps. The study was conducted in one of the public health units in the Manzini Region 
of Swaziland. The qualitative, exploratory and descriptive research design was used 
and data collection was done using individual interviews and field notes. Permission 
was also requested from the participants in order to record the interviews. Population of 
the study were all cases of HIV positive pregnant mothers enrolled on PMTCT Option 
B+ programme, and were aged between 18 and 40 years. Number of participants 
sampled was 20 and only 17 participants were interviewed. Themes of the study were: 
perceptions of being enrolled on the PMTCT Option B+ programme, understanding 
about PMTCT Option B+ programme and information needed with regard to PMTCT 
Option B+ programme, perceptions with the care received from the nurses and their 
assistance on PMTCT Option B+ programme, effectiveness of the PMTCT Option B+ 
programme and challenges of taking ARVs. The findings revealed that Option B+ 
programme was perceived as preventing HIV from mother-to-child. It boosts the 
mother’s immune system, prevents opportunistic infections and prolongs life. 
Knowledge and understanding of the programme was displayed by the participants 
even though challenges such as discrimination and no support by families and partners 
were mentioned. Improvement of the programme on how to prevent the spread of HIV 
to babies and strategies to assist participants on how to disclose were recommended. 
This was found to be having a huge effect on treatment adherence. 
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virus; mother-to-child transmission; perceptions; prevention; public health unit. 
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                                         CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
Mother-to-child transmission (MTCT) is the transmission of the human 
immunodeficiency virus (HIV) from an infected mother to her child. This can occur 
during pregnancy, labour and delivery, and breastfeeding (Hadebe 2012:13; Swaziland 
Ministry of Health2010a:4). Through research, prevention of mother-to-child 
transmission (PMTCT) of HIV programme was established. The PMTCT is a highly 
effective intervention which ensures that an HIV infected mother does not pass the 
infection to her child. This is implemented through administering medication 
(antiretroviral drugs) to mothers during pregnancy, labour, delivery, and to their 
breastfeeding babies. If well implemented, Swaziland will be able to reduce MTCT rates 
to less than 5% by 2015 (Hadebe 2012:13; Swaziland Ministry of Health 2010a:4).  
 
Recent research about Swaziland’s HIV national statistics showed that the effectiveness 
of PMTCT programme in Swaziland is about 95 % (HIV and AIDS in Swaziland 2012:1). 
As good as this progress is, 33% of HIV-infected pregnant women do not access 
PMTCT services as three quarters of the Swazi population lives in rural areas, outside 
cities where  health facilities are not available, contributing to an excess of infant HIV 
infection and deaths (Swaziland Ministry of Health 2010a:10; Ministry of Health, 
Kingdom of Swaziland 2016:9; WHO 2012:1).The recent internal statistics at the 
researcher’s workplace prompted the researcher to explore and describe perceptions of 
Human Immunodeficiency Virus positive mothers on prevention of Mother-to-Child 
Transmission, Option B+ programme in a public health Unit in Manzini. 
 
1.2 BACKGROUND TO THE RESEARCH PROBLEM 
 
Approximately 33,000 deliveries are registered every year in Swaziland. With HIV 
prevalence among pregnant women of 41.1%, and they give birth to over 17000 HIV 
exposed infants each year. Babies born to HIV-positive mothers are at risk of getting 
HIV during pregnancy, labour, delivery and or when breastfeeding. In response to this 
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situation the government of Swaziland has made the PMTCT of HIV a top priority  to 
combat  HIV infection in children in the country (Swaziland Ministry of Health 2010a:10; 
Swaziland Ministry of Health2012:10). The Swaziland Ministry of Health (MOH)  with the 
support from organizations such as Elizabeth Glazer Paediatric AIDS Foundation 
(EGPAF), International Center for Aids Prevention Programmes (ICAP), United Nations 
Children’s Fund (UNICEF), and other partners had joint forces to combat HIV infection 
in children so that they can be an HIV free future generation through the PMTCT 
programme. 
 
In Swaziland the programme was officially launched in 2003 with support from World 
Health Organization (WHO), and has made tremendous progress in implementation of 
PMTCT services, beginning with only three facilities in 2003 and increasing to 137 
facilities by 2009 (Swaziland Ministry of Health 2012:1).The percentage of HIV positive 
pregnant women who received antiretroviral treatment to reduce the risk of mother-to-
child transmission had increased to 62.45 % by 2008 (The Government of the Kingdom 
of Swaziland 2008:26). In 2003, a single dose nevirapine (sd-NVP) was provided for 
mothers and infants to reduce MTCT in Swaziland. Since 2007, a dual ARV regimen of 
zidovudine (AZT) and NVP has been used with a 7 day ‘tail’ of AZT+ Lamivudine (3TC) 
to minimize NVP resistance. With the new 2010 guidelines, more efficacious ARV 
regimens are being made available for HIV-infected women and their infants, and these 
include use of ARV for HIV-exposed infants who are breastfeeding. This is a way to 
make breastfeeding safer for women with HIV, and ARV prophylaxis may begin earlier 
in pregnancy. This is as early as 14 weeks gestation (Swaziland Ministry of Health, 
2010a:10; Swaziland Ministry of Health2012:1).  
 
The PMTCT programme offers a package of services that include counselling and 
testing; prevention of HIV transmission among pregnant and lactating women who 
initially test HIV negative; antiretroviral (ARV) drugs prophylaxis to both infected women 
and their exposed infants; counselling and support for safe infant feeding practices; 
family planning, and referral for long-term antiretroviral therapy (ART) for the child and 
the mother. The objective of PMTCT is to eliminate new infections among children and 
keep mothers alive. PMTCT interventions will contribute to the achievement of the 
outcome which is the percentage of HIV infected infants aged 6-8 weeks who are born 
to HIV positive mothers reduced from 2% in 2011 to 1% in 2015 and maintained at 1% 
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in 2018 (The Extended National Strategic Framework (eNSF) for HIV and AIDS 2012-
2014:30). 
The ultimate goal for PMTCT is to reduce Mother-to-Child transmission and therefore 
interventions provided to the child are of great importance. In the absence of PMTCT 
interventions about 15-25% of infants of women living with HIV will be infected during 
pregnancy or delivery, and in addition 5-20% may become infected during breastfeeding 
(Swaziland Ministry of Health2012:16). 
 
Studies in Swaziland have shown that during 2012, around 81% of pregnant women 
were being tested for HIV per year and 83% of those testing positive received 
antiretroviral treatment to prevent transmission of HIV to their babies. An estimated 15% 
of children born to HIV positive mothers were infected with HIV in 2011 (HIV& AIDS in 
Swaziland 2012:1). During 2012, 9414 exposed infants were seen in child welfare 
clinics at the six-week visit post child birth in Swaziland, and below is a table that shows 
PMTCT statistics in the four regions of Swaziland in 2012, according to Swaziland 
National PMTCT Program (2012:17). 
 
Table 1.1 Infants born to HIV positive women in four regions Swaziland 
 
Region Infants born to HIV positive women 
Hhohho 2641 
Manzini 2005 
Lubombo 3184 
Shiselweni 1584 
(Swaziland Ministry of Health 2012:17) 
 
The study site is a Public Health Unit located in the Manzini region of Swaziland. The 
tables below show statistics of children tested HIV positive in the years 2010-2012 in 
the Manzini region, according to Swaziland National PMTCT Programme (2012:17). 
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Table 1.2 Proportion of infants tested HIV positive by age, in each quarter year 
2010 in Manzini region 
 
Age Q1-2010 Q2-2010 Q3-2010 Q4-2010 
<=8 weeks 77 77 72 64 
12 months 153 139 151 94 
>12 months 56 30 29 19 
(Swaziland Ministry of Health 2012:17) 
 
Table 1.3 Proportion of infants tested HIV positive by age, in each quarter 
year 2011 in Manzini region 
 
Age Q1-2011 Q2-2011 Q3-2011 Q4-2011 
<=8 weeks 47 38 52 41 
12 months 125 95 115 94 
>12 months 36 23 22 41 
(Swaziland Ministry of Health 2012:17) 
 
Table1.4 Proportion of infants tested HIV positive by age, in each quarter 
year 2012 in Manzini region 
 
Age Q1-2012 Q2-2012 Q3-2012 Q4-2012 
<=8 weeks 92 47 72 47 
12 months 136 72 74 86 
>12 months 87 17 27 24 
(Swaziland Ministry of Health 2012:17) 
 
In Swaziland, the MOH adopted PMTCT Option A as a feasible and less costly way to 
scale up the PMTCT services nationwide. Despite major success since the programme 
started some barriers exist for continued work in 2013, including that follow up care for 
pregnant HIV positive women still remains a challenge (Swaziland Ministry of 
Health2012:5). However, based on the limitations experienced with widespread 
implementation, the MOH is taking steps to examine alternative approaches to PMTCT 
including a modified Option B approach, where all pregnant women initiate lifelong triple 
ARV therapy (Option B+), and the engagement of HIV positive women in lifelong HIV 
services which will reduce the delays in ART initiation and as well as loss to follow up 
(Abrams 2014:11). The Swaziland Annual HIV Programmes Report indicated that the 
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number of HIV infected infants aged 6-8 weeks was 2% in 2011 (United States Agency 
International Development[USAID] and Institute of Health Management [IHM] (2014:16), 
whilst an evaluation report done in August 2014 states that the percentage of HIV 
infected infants aged 6-8 weeks was 3% in 2014 (USAID 2014:16). 
 
The above statement indicates that there is still increase in the number of children who 
tested positive with PMTCT Option A. The study investigates the perceptions of HIV 
positive pregnant mothers regarding the PMTCT Option B+ programme that has been 
recently implemented in the country.  
 
1.3 THE RESEARCH PROBLEM 
 
Although the Government of Swaziland has demonstrated a high level of commitment to 
the virtual elimination of paediatric infection due to MTCT of HIV by 2015, there is still a 
significant increase in the number of HIV positive children born. The Swaziland PMTCT 
statistics showed a 1% increase of babies who were born infected with HIV in 2014. The 
percentage of HIV infected infants aged 6-8 weeks was 3% in 2014 compared to 2% in 
2011(USAID & IHM 2014:16). This increase prompted the researcher to explore and 
describe the perceptions of HIV positive pregnant mothers regarding the PMTCT, 
Option B+ programme in a Public Health Unit in Manzini. 
 
1.4 AIM OF THE STUDY 
 
1.4.1 Research purpose 
 
The purpose of the study was to explore and describe the perceptions of the HIV 
positive pregnant mothers regarding the PMTCT, Option B+ programme in a Public 
Health Unit in Manzini. 
 
1.4.2 Research objectives 
 
The objectives of the study were to: 
 
 Explore and describe the perceptions of the HIV positive pregnant mothers with 
regards to PMTCT Option B+ programme in a Health Unit in Manzini. 
 Describe the challenges encountered by the HIV positive pregnant mothers when 
taking ARV’s in a Health Unit in Manzini. 
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 To make recommendations to policy makers regarding the improvement of the 
PMTCT Option B+ programme to prevent the spread of HIV infection to babies. 
 
1.4.3 Research questions 
 
These three key questions, among others, guided the investigation: 
 
 What are the perceptions of the HIV positive pregnant mothers with regard to 
PMTCT Option B+ programme in in a Public Health Unit in Manzini? 
  What are the challenges encountered by the HIV positive pregnant mothers 
when taking ARV’s in a Public Health Unit in Manzini? 
 What recommendations should the study make to policy makers regarding 
PMTCT Option B+ programme to prevent the spread of HIV infection to babies? 
 
1.5 SIGNIFICANCE OF THE STUDY 
 
The researcher envisages the findings of the study would assist the Swaziland Ministry 
of Health to strengthen the body of knowledge for health care workers in the area of 
Public Health. The study will enable the development of guidelines and 
recommendations to policy makers that would assist in the prevention of HIV infection 
from the HIV positive mothers to their babies. The study would also inform practice on 
what would be the best option for practitioners to follow hence addressing the gaps 
related to PMTCT Option B+ programme. The study will also form the basis for further 
investigation in future studies. 
 
1.6 DEFINITION OF TERMS 
 
1.6.1 AIDS 
 
AIDS is the abbreviation of Acquired Immune Deficiency Syndrome. AIDS is an illness 
that impairs the body’s ability to fight infection with the result that the body is extremely 
susceptible to life threatening disease. AIDS represent the terminal phase of the HIV 
infection (Ndzimandze 2009:36). In the context of this study AIDS is discussed as an 
illness acquired once a person is HIV positive and has life threatening illness. 
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1.6.2 Describe 
 
Describe is defined as give a detail account in words of (someone or something), 
including all the relevant characteristics, qualities, or events (Oxford Dictionary of 
Current English 2006: 239& Macmillan Dictionary 2017,”context”). In the context of the 
study HIV positive pregnant women gave in detail their perceptions towards PMTCT 
Option B+ programme. 
 
1.6.3 Explore 
 
Explore is defined as inquire into or discuss in detail, to investigate, study, or analyze 
(Merriam Webster 2017,”context”). 1 &Oxford Dictionary of Current English 2006:314). 
In this study, HIV positive pregnant women discussed in detail their perceptions and 
effectiveness of the PMTCT programme during the conducting of semi-structured 
interviews with them. 
 
1.6.4HIV 
 
HIV is the abbreviation for Human Immunodeficiency virus. HIV is present in all body 
fluids, but is more infectious in the blood, semen and vaginal fluid of infected person. 
The virus attacks and destroys a particular group of cells that are important in regulating 
the normal body defenses against infecting organisms and foreign cells and proteins. As 
more of the cells are destroyed with time, the body is less able to defend itself from 
many infections and disease (Ndzimandze 2009:36, 39).In the study HIV is discussed in 
the context of PMTCT Option B+ programme as it is transmitted from HIV positive 
pregnant mother to her unborn baby. 
 
1.6.5 Mother-to-child transmission (MTCT) 
 
Mother-to-child transmission (MTCT) is defined as the transmission of HIV from an 
infected mother to her child (Hadebe 2012:13). Transmission of HIV from mother to 
child can occur at any point during pregnancy, labour, and delivery, or through 
breastfeeding milk after the baby is born (Baylor International Paediatric AIDS Initiative 
(BIPAI) 2010:3; 91).In the context of this study Mother-to-child transmission is 
discussed as a mode that spread HIV from HIV positive mother to her child. 
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1.6.6 Perceptions 
 
Perceptions are defined as the processes by which people translate sensory 
impressions into a coherent and unified view of the world around them, though 
necessarily based on incomplete and unverified information, perceptions are equated 
with reality for most practical purposes and guides human behaviour in general 
(Mokaba 2013:8). In the context of this study, perceptions refer to the ability of HIV 
positive pregnant mothers to self-report opinions, attitudes, fears and to understand 
PMTCT Option B+ programme in order to prevent the spread of HIV infection to their 
babies. 
 
1.6.7 Prevention 
 
Prevention refers to the act of stopping something bad from happening (Oxford 
Advanced Learners Dictionary 2010:1160). In this study, the PMTCT Option B+ 
programme is investigated if it can stop the transmission of HIV from mother-to-child 
during pregnancy, delivery, and breastfeeding by using antiretroviral treatment. Illness 
or disease prevention is behaviour motivated by a desire to avoid or detect disease, or 
maintain functioning within constrain of illness or disability (Taylor, Lillis, LeMone& Lynn 
2011:47).  In this study the PMTCT option B+ programme is investigated if it can 
prevent the transmission of HIV from mother-to-child during pregnancy, delivery, and 
breastfeeding by using antiretroviral treatment.  
 
1.6.8 Public health unit 
 
Public health unit is an official health agency established by a group of urban and rural 
municipalities to provide a more efficient community health programme, carried out by 
full-time, especially qualified staff (Ontario Ministry of Health and Long-Term Care 
2014:1). According to Joubert and Ehrlich (2012:4), a public health can be defined as 
one of the efforts organized by a society to protect, promote and restore the heath of a 
population. It is a combination of sciences, skills and beliefs that are directed to the 
maintenance and improvement of the heath of the people through collective and social 
action. The scope of public health unit is comprehensive, i.e. incorporating prevention 
as well as treatment, and considering the health system as a whole and the way the 
different levels of the system support each other. The study was conducted in one 
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Public Health Unit in Manzini where PMTCT programme is offered to HIV positive 
pregnant mothers. The PMTCT programme assists in preventing transmission of HIV 
from Mother-to-Child by restoring the health of HIV positive pregnant mothers in the 
community thus increasing an HIV free population in the community. The ultimate goal 
for PMTCT is to reduce Mother-to-Child transmission and therefore interventions 
provided to the child are of great importance (Swaziland Ministry of Health 2012:16). 
 
1.7 RESAERCH DESIGN AND METHODS 
 
The qualitative approach used in this study is explained in detail in Chapter 3. 
 
1.8 SCOPE OF THE STUDY 
 
The research was conducted in one Public Health Unit of Manzini Region. This 
particular unit was purposefully selected because it is one of the pilot sites where 
PMTCT Option B+ programme was implemented. Therefore, selected samples may not 
be fully representative and the findings may not be generalized, in the fullest sense, to 
the whole of Manzini Region or Swaziland.  
 
1.9 STRUCTURE OF THE DISSERTATION 
 
The report of the research is presented in the following format: 
 
Chapter 1 gives the orientation and serves as an introduction to the study. 
Chapter 2 focuses on the literature review of perceptions held by HIV pregnant mothers 
regarding PMTCT Option B+ programme. 
 
Chapter 3 presents the research design and method. 
 
Chapter 4 focuses on analysis, presentation and description of the research findings. 
 
Chapter 5 consists of conclusion and recommendations. 
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1.10 CONCLUSION 
The chapter gave an overview of the study. It covered the background and nature of 
problem to be studied, as well as the aim and significance of the study. Key terms were 
defined, and the structure of the dissertation given. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
Literature review is a review or further look at what has previously been written on a 
particular subject (Joubert & Ehrlich 2012:66). The primary purpose of literature review 
is to intergrate research evidence to sum up what is known and what is not known. 
Literature review also helps researchers to interpret their findings (Polit & Beck 
2014:116). Literature review is therefore intended to convey to the reader the current 
state of knowledge on a given subject along with the strengths and limitations of the 
underlying research (Joubert & Ehrlich 2012:66). 
 
The previous chapter gave an overview of PMTCT programme, and this chapter 
presents a critical review of the related literature on perceptions of HIV positive 
pregnant mothers regarding PTMCT Option B+ programme. Literature reviewed on this 
chapter focuses on the overview of PMTCT, PMTCT Option B+ programme and 
benefits of PMTCT Option B+ programme. 
 
2.2 OVERVIEW OF PMTCT AND PMTCT OPTION B+PROGRAMME 
 
2.2.1 Global history of PMTCT 
 
The prevention of mother-to-child of HIV intervention programme is a strategy to 
prevent vertical transmission of HIV from mother to the unborn child (Thithi 2014:13). 
Effective PMTCT programmes require women and their infants to recieve a cascade of 
interventions including uptake of antenatal services and HIV testing during pregnancy, 
use of antiretroviral treatment (ART)  by pregnant women living with HIV, safe child birth 
practices and apropriate infant feeding, uptake of infant HIV testing and other post natal 
health care services (AVERT 2015:1).  
 
In 2011, a global plan was launched to reduce the number of new HIV infection via 
MTCT by 90 percent in 2015. WHO identified 22 priority countries with the top 
10(Angola, Botswana, Burundi,Cmeroon, Chad, Cote d’lvoire, Democratic Republic of 
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the Congo, Ethopia,Ghana and India) accounting for the 75 percent of the global 
PMTCT services need. It was estimated that the effective scaling up of PMTCT 
interventions in these countries would prevent over 250,000 new infections annually 
(AVERT 2015:1).  
 
2.2.2 History of PMTCTinSwaziland 
 
About 41 percent of pregnant women in Swaziland are infected with HIV and they give 
birth to over 17 000 HIV-exposed infants earch year. In response to this situation the 
Government of Swaziland has made the prevention of mother-to-child transmission a 
top priority (WHO 2012:1). Swaziland’s PMTCT programme was officially launched in 
2003, with the support from WHO, UNICEF, The Elizabeth Glasser Pediatric AIDS 
Foundation and other partners. From an initial three pilot sites in 2003, the national 
PMTCT programme grew to 150 sites by 2010 (WHO 2012:1).   
 
2.2.3 Progress in the PMTCT global 
 
In 2012, over 900,000 pregnant women living with HIV globally who accessed PMTCT 
services had a coverage of 62 percent. Four priority countries (Botswana, Ghana, 
Namibia and Zambia), had recieved 90 percent PMTCT coverage (AVERT 2015:1). In 
many countries, less than half of HIV positive pregnant mothers with a CD4 count under 
350 (the treshold for ART initiation under the 2010 WHO treatment guidelines), recieved 
ART for their own health (AVERT 2015:1).  Indeed , HIV prevention for pregnant women 
varies greatly between regions with over 90 percent accessing these services in 
Eastern and Central Europe and Caribbean compared to less than 20 percent in Asia 
and the Middle East and North Africa (AVERT 2015:1).  
 
There was also PMTCT progress among children. Between 2011 and 2012, new HIV 
infection in children fell by 52 percent. However, in 2012, there were still an estimated 
260,000 new HIV infections among these group (AVERT 2015:1).  Moreover there is an 
even bigger gap in ART provision for the children living with HIV. In 2012, only 34 
percent of under fifteen years living with HIV received ART − nearly half adult coverage. 
In priority countries, only 30 percent of children received HIV treatment (AVERT 
2015:1). 
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2.2.4 PMTCT progress in Swaziland 
 
Swaziland has made commendable progress in recent years. PMTCT services are 
intergrated within maternal, newborn, and child health services to ensure that they 
identify and care for as many HIV positive mothers and chidren as posible 
(WHO:2012:1). Based on WHO’s 2010 guidelines on the use of ART for treating 
pregnant mothers and preventing of HIV infection in infants, the country has made more 
effective drug regimens available that reduce the risk of mother-to-child transmission to 
less than 5 percent. In addition all HIV exposed infants are tested at six weeks of age 
(WHO 2012:1). 
 
2.2.5 Comprehensive approach to PMTCT 
 
According to the Swaziland Ministry of Health (2010a:12) and Baylor International 
Paediatric AIDS Initiative 2010:92), Prevention of Mother-To-Child transmission of HIV 
is implemented through a four-pronged approach which is as follows: 
 
 Prong 1: primary prevention of HIV infection among women of child bearing age. 
Women and partners who test HIV negative should stay negative as women who 
are not infected cannot transmit HIV perinatal to a child. Emphasis on HIV 
prevention through practice of safe sex and consistent use of condoms as a safe 
sexual behaviour during pregnancy and breastfeeding period with their partners. 
 Prong 2: prevention of unintended pregnancies among HIV positive women. It 
includes counselling and provision of family planning to HIV infected women to 
prevent unwanted pregnancies.  
 Prong 3: prevention of MTCT from HIV positive women to their babies during 
pregnancy, labour and breastfeeding periods through the use of maternal and 
infant ARV prophylaxis, ART, good obstetric practices and monitoring of labour 
and delivery. 
 Prong 4: care support and treatment for HIV positive women and their families. 
HIV treatment, care and support services are provided for the mother, infant and 
family respectively. 
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2.2.6 PMTCT Option B and B+ programme 
 
The Global Plan towards the elimination of new HIV infections among children by 2015 
and keeping their mothers alive is well underway, with ambitious goals of reducing the 
number of new HIV infections in children by 90% (UNICEF 2012:2). There is now 
unprecedented collaboration to accomplish these goals and many countries have made 
exceptional progress. An AIDS-free generation is within reach, and this is possible 
through a new approach called Option B+, and has already shown an impressive 
results, dramatically increasing the numbers of pregnant women enrolling on ART 
(UNICEF 2012:2). 
 
Under WHO’s 2010 PMTCT ARV guidance with Option B all pregnant and lactating 
mothers with HIV initially are offered ART-beginning in the antenatal period and 
continuing throughout the duration of breastfeeding. At the end of breastfeeding those 
women who do not require ART for their own health would discontinue the prophylaxis 
and continue to monitor their CD4 count, eventually restarting ART when their CD4 falls 
below 350 cells/mm3. (UNICEF 2012:2). 
 
With PMTCT Option B+ programme, all pregnant women living with HIV are offered 
lifelong ART; regardless of their CD4 count (UNICEF 2012:2). 
 
Table 2.1 Summary of Option B and B+ treatment 
 
Options Treatment for CD4 count<350 cells/mm3 
Prophylaxis for CD4 
count >350 
cells/mm3 
Treatment for infant 
B Triple ARVs starting 
as soon as 
diagnosed, continue 
for life  
Triple ARVs starting 
as early as 14 weeks 
gestation and 
continued intrapartum 
and through child 
birth if not 
breastfeeding or until 
one week after 
cessation of all 
breastfeeding 
Daily NVP or AZT 
from birth through age 
4  to 6 weeks 
regardless of infant 
feeding method 
B+ Triple ARVs starting 
as soon as 
diagnosed, continue 
for life 
B+ Triple ARVs 
starting as soon as 
diagnosed, continue 
for life 
 
Daily NVP or AZT 
from birth through age 
4 to 6 weeks 
regardless of infant 
feeding method 
(Adapted from UNICEF 2012:2) 
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2.2.6.1 History of implementation of PMTCT Option B+ programme 
 
In 2012, World Health Organization (WHO) recommended that countries consider 
moving to PMTCT Option B or B+ programme. WHO formalized this recommendation in 
its 2013 consolidated ARV guidelines, recommending that countries adopt Option B or 
B+ programme, thereby removing the step of CD4 testing before ART initiation in 
pregnancy. These guidelines also recommended providing ART in maternal and child 
health (MCH) settings (Kukiabor, Katirayi, Nhlabatsi & Mahdi 2014:1). 
 
Option B+ programme was first conceived and implemented in Malawi where the 
National ART programme had already been functioning well using a public health 
approach which did not depend heavily on CD4 testing to determine who should initiate 
treatment  (UNICEF 2012:3). In April 2012, in response to Malawi’s early success and 
other strategic and technical developments WHO released an important programmatic 
update on the “use of Antiretroviral Drug for treating pregnant women and Prevention of 
HIV infection in infants” (UNICEF 2012:3), which is Option B+ programme. 
 
Between 2012 and 2013, Lesotho, Uganda, Mozambique, and Tanzania began 
implementation of PMTCT Option B+ programme, and large increases were 
immediately seen in the percentage of pregnant mothers accessing ART in antenatal 
care (ANC) (Kukiabor et al 2014:1). 
 
2.2.6.2 Implementation of PMTCT Option B+ programme in Swaziland 
 
Since 2013, an innovative approach, commonly referred to as prevention of mother-to-
child transmission Option B+ programme (PMTCT Option B+ programme) was being 
rolled out by M’edecins Sans Froniesres (MSF) and the Swaziland Ministry of Health 
(MSF 2013:1). With the prevalence of HIV/AIDS among pregnant mothers currently 
close to 40% is extremely worrying, and without treatment, 25 to 40% of the children 
born from HIV positive pregnant mothers will also be infected (MSF 2013:1). With the 
PMTCT Option B+ programme approach implemented, Swaziland will be able to 
decrease the number of HIV positive babies born. As of March 2014, 10% of facilities in 
Swaziland are providing PMTCT Option B+ programme (Kukiabor et al 2014:1).  
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2.2.7 Benefits of PMTCT Option B+ programme 
 
The benefits of PMTCT Option B+ programme are as follows: 
 
 Reduce new number of HIV infection among children, reduce suffering from 
HIV/AIDS children and those affected (Swaziland Ministry of Health 2006:13). 
 Increase maternal life expectancy- allow HIV positive mothers to live longer by 
reducing the risk of opportunistic infections (MSF 2013:1). 
 Provide opportunity to early and comprehensive care for the mother, partner and 
family members in need of HIV services(Swaziland Ministry of Health 2006:13) 
 Prevent transmission of the virus in future pregnancy (MSF 2013:1). 
 
2.3 ACCEPTABILITY OF PMTCT OPTION B+ PROGRAMME BY PREGNANT 
MOTHERS 
 
The Swaziland Ministry of Health and Elizabeth Glaser Paediatric Aids Foundation 
(EGPAF) in 2012 conducted a study on barriers to ART initiation for eligible HIV positive 
pregnant mothers in ANC, using the focus group method among pregnant mothers who 
did and did not accept ART among eligible women. Although all the women face similar 
barriers of stigma and disclosure, distance to the facility, cost of transport, lack of 
knowledge about ART, and anxiety about lifetime commitment were reported. Some 
pregnant mothers were also reported as being scared and traumatized by the 
seriousness of the commitment to life-long ART and that acceptance of ARV 
prophylaxis was easier (Kukiabor et al 2014:1).  
 
In a Malawi study, women diagnosed with HIV and offered ART initiation on the same 
day reported feeling overwhelmed with having to cope with the HIV diagnosis, 
disclosure to their partner or family, and having to initiate lifelong ART (EGPAF 2014:1). 
 
2.4 OTHER COUNTRIES VIEWS ABOUT PERCEPTIONS OF HIV POSITIVE 
PREGNANT MOTHERS REGARDING PMTCT OPTION B+ PROGRAMME 
 
Pregnant women are the PMTCT recipients, therefore have their own personal 
experiences regarding PMTCT Option B+ programme which can either be good or bad 
depending on how they perceive the programme. A study conducted by Ngarina, 
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Tarimo, Naburi, Kilewo, Mwanyika-Sando, Chalamilla, Biberfeld and Ekstrom (2014:1) 
in Tanzania about women’s preferences regarding ARV prophylaxis for PMTCT of HIV 
and views on Option B+ programme were as follows:  
 
 There was perceived stigma of giving medicine to the child every day. They 
explained how hard it was, giving medicine to a healthy baby everyday 
throughout the breastfeeding period. It was very easy to be noticed when doing 
something a bit unusual like giving a baby believed to be healthy medicine every 
day. 
 There was the perception that the child was too innocent to take ART. Several 
mothers were against giving the drug daily to a new-born because they 
perceived it as a sort of punishment to an innocent child especially when the 
baby was healthy; they thought the mother will be more tolerable to take 
medication than the child.  
 There was eagerness to prolong life through Option B+ programme.  They think 
that this will help them live a better and a longer life enabling them to raise their 
children for a much longer time before they die (UNICEF 2012:20).  
 
Findings on a study conducted by Thithi (2014:67), on perceptions of pregnant women 
about the PMTCT of HIV programme at the antenatal care unit and maternity ward at 
the Jordan Heynes community, were that: 
 
 The women stated that the first antenatal visit was very emotional for them 
because of the news they had received about their HIV status and having to 
start new programme that same day. 
  They felt it was made worse by the fact that they were clueless and naive about 
the PMTCT programme. Most of them were conflicted about whether or not to 
start the treatment and were worried about whether taking the treatment would 
harm or protect their babies. 
 Regarding their views these pregnant women indicated that they have come to 
realise that they had played the most important role in ensuring the success of 
the PMTCT programme, because though the midwives are available to provide 
all the services at the clinic, like counselling and treatment, it ultimately is their 
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choice about whether or not they take the treatment. They all know that failure to 
adhere will lead to their babies having a great chance of testing HIV positive. 
 
2.5 CONCLUSION 
 
This chapter reviewed literature related on PMTCT, PMTCT Option B and PMTCT 
Option B+ programmes. Progress made globally and in Swaziland, in terms of PMTCT 
programme, was also addressed. The chapter also reviewed previous studies about 
perceptions of HIV positive pregnant women regarding PMTCT Option B+ programme. 
The next chapter addresses the research methodology that was used to conduct the 
study. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHOD 
 
3.1 INTRODUCTION 
 
This chapter presents the research design and method that were used to conduct the 
study. Sampling, population, ethical issues, data collection methods and instruments, 
data analysis, and measures to ensure trustworthiness were also discussed. The 
purpose of the study was to explore and describe the perceptions of the HIV positive 
pregnant mothers regarding the PMTCT, Option B+ programme in a Public Health Unit 
in Manzini. 
 
3.2 THEORETICAL GROUNDING OF RESARCH 
 
Qualitative research is grounded on the constructivist paradigm. Constructivist studies 
are heavily focused on understanding the human experience as it is lived, usually 
through the collection and analyses of qualitative materials that are narrative and 
subjective. Constructive researchers tend to emphasize the dynamic, holistic, and 
individual aspects of human life and attempt to capture those aspects in their entirety, 
within the context of those who are experiencing them (Polit & Beck 2012:14). 
 
Ontology in the constructivist assumption is that reality is multiple and subject and 
effective, mentally constructed by individuals; simultaneously shaping, not cause and 
effect (Polit &Beck 2012:13). In the context of this study, the researcher interpreted the 
data according to the understanding of what the participants revealed to her. 
 
Epistemology in the constructivist paradigm assumption is that the inquirer interacts 
with those being researched; findings are the creation of the interactive process (Polit & 
Beck 2012:13). In the context of this study epistemology refers to direct or closely 
interaction between the researcher and the participants and the findings being reported 
in the form of written verbal description. 
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An axiological question is “what is the role of values in the enquiry?”                  
Axiology in the constructivist paradigm assumption is that subjectivity and values are 
inevitable and desirable (Polit & Beck 2012:13). In the study the personal values of the 
researcher did not influence the values of the participants during data collection; 
participant’s values were be respected.  
 
Rhetoric is defined as speech or writing that is intended to influence people, but that is 
not completely honest and sincere; or is the skill of using language in speech or writing 
in a special way that influences or entertains people (Oxford Advanced Learners 
Dictionary 2010:1269). The study was written in a language understandable and can be 
used to expand knowledge or innovate to other researchers for study. 
 
3.3 RESEARCH DESIGN 
 
Research design is the overall plan for obtaining answers to the research questions and 
for handling challenges that can undermine the study evidence. It indicates how often 
data will be collected, what types of comparisons will be made and where the study will 
take place (Polit & Beck 2014:51). The qualitative, exploratory and descriptive research 
design was opted for this study to explore and describe the perceptions of HIV positive 
pregnant mothers regarding PMTCT Option B+ programme, and make 
recommendations to improve the programme in order to prevent the spread of HIV 
infection to babies. The main reason for adopting this design is to explore and describe 
the perceptions of HIV positive pregnant mothers with regard to PMTCT Option B+ 
programme at a Public Health Unit in the Manzini region of Swaziland. This is one of the 
pilot sites where PMTCT Option B+ programme is implemented. 
 
3.3.1 Qualitative research 
Qualitative research is the investigation of phenomena typically an in-depth and holistic 
fashion, through the collection of rich narrative materials using a flexible research 
design (Polit & Beck 2014:389). The reason why qualitative research method was used 
for this study is because it takes place in a natural setting where human behaviour and 
events take place. Researchers who use this paradigm are usually interested in 
understanding a particular social situation, event, role or interaction, as in this case of 
exploring and describing the perceptions of HIV positive pregnant mothers regarding 
PMTCT Option B+ programme in a Public Health Unit in Manzini. The paradigm 
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enabled HIV positive pregnant mothers to provide detailed information without 
restriction of the researcher.  
 
3.3.2 Exploratory research 
 
An investigation conducted using exploratory research explores the dimension of a 
phenomenon or that develops or refines hypothesis about relationships between 
phenomena (Polit & Beck 2012:727). In this study, the researcher used this research 
type to explore the perceptions of the HIV positive pregnant mothers with regards to 
PMTCT Option B+ programme. 
 
3.3.3 Descriptive research 
 
Descriptive research is research that typically has as its main objective the accurate 
portrayal of people’s characteristics or circumstances and/or the frequency with which 
certain phenomena occur; it attempts to describe a phenomenon (Polit & Beck 
2012:725). According to Burns and (Groove 2009:45) descriptive design is used to 
generate new knowledge about topics on which limited or no research has been 
conducted. Therefore, descriptive research is suitable for this study because it intends 
to describe the perceptions of the HIV positive pregnant mothers with regard to PMTCT 
Option B+ programme. 
 
3.4 RESEARCH METHOD 
 
Qualitative research concentrates on qualitative aspects such as meaning, experience 
and understanding. It is the approach in which the procedures are formalized and 
explicated in a non-strict manner, but in which the scope is less defined in nature and in 
which the researcher does the investigation in a more philosophical manner 
(translation), Mouton and Marais (1989:157). In the context of this study, qualitative 
approach was chosen since the main purpose of the study was to explore and describe 
the perceptions of the HIV positive mothers regarding the PMTCT Option B+ 
programme at one public health unit in Swaziland. The participants were interviewed 
about their perceptions regarding the PMTCT Option B+ programme. 
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In this section, the research method that was used is discussed under the following 
headings: 
 
3.4.1 Sample 
A sample is a representative of the study population or a subset of population element 
(Joubert & Ehrlich 2012:94; Polit & Beck 2014:177). The representatives of the study 
were HIV positive pregnant mothers who had enrolled on the PMTCT Option B+ 
programme and volunteered to participate in the study. Polit and Beck (2012:521) state 
that there are no fixed rules for sample size in qualitative studies, hence the guiding 
principle in sample size is determined by the data saturation- that is sampling to a point 
at which no new information is obtained and redundancy is achieved. The sample size 
for this study was determined by data saturation. The researcher had intended to 
interview 20 HIV positive pregnant mothers who had enrolled on the PMTCT Option B+ 
programme. However, the researcher managed to interview 17 HIV positive pregnant 
mothers who had enrolled on the PMTCT Option B+ programme and thereafter data 
saturation was reached. 
 
3.4.2 Inclusion criteria 
The selection criterion for the study was that participants had to be: 
 
 HIV positive pregnant mothers speaking Siswati language at least between the 
ages of 18-40 years. 
 Enrolled in the PMTCT Option B+programme during the current pregnancy. 
 Attending antenatal care service in a Public Health Unit in Manzini, the study site.  
 Willing to participate voluntarily. 
 
3.4.2.1 Population 
 
The population is the entire aggregation of cases in which the researcher is interested, 
and might consist of all hospital records, and comprises the aggregate of elements in 
which the researcher is interested (Polit & Beck 2012:273-275). According to Polit and 
Beck (2012:274) as well as Joubert and Ehrlich (2012:94), target population is the 
aggregate of cases about which the researcher would like to generalise and the group 
the researcher wants to gather information and draw conclusions. The target 
populations in the study were HIV positive pregnant mothers who enrolled on the 
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PMTCT Option B+ programme. Polit and Beck (2012:274), also state that accessible 
population is the aggregate of cases that conform to designated criteria and are 
accessible for a study. In this study, all cases of HIV positive pregnant mothers who had 
enrolled on PMTCT Option B+ programme were identified and accessible to participate 
in the study.  
 
3.4.2.2Sampling 
 
Sampling is the process of selecting a portion of the population to represent the entire 
population (Polit & Beck 2012:742), and the important component of the sampling 
process is determining the appropriate sample size (Joubert & Ehrlich 2012:190). 
 
Qualitative researchers establish the kind of people who are eligible to participate in 
their research (Polit & Beck 2012:555), therefore, the researcher in this study identified 
only eligible participants who were all HIV positive pregnant mothers and enrolled in 
PMTCT Option B+ programme during the current pregnancy in a Public Health Unit in 
Manzini. 
 
3.4.2.3    Research setting 
 
The research setting refers to the physical location and conditions under which data 
collection takes place in the study (Polit & Beck 2012:743). This study was conducted in 
a semi urban setting, in one Public Health Unit of Manzini Region. The facility caters for 
out-patients and offers preventive services and public health programme. Services 
offered include provider initiated HIV testing and counseling (PIHTC), PMTCT, ART, 
antenatal care (ANC), child welfare services (CWF), sexual transmission infection (STI) 
treatment, laboratory services, etc. The choice of the unit was influenced by that this 
facility is one of the pilot sites where PMTCT Option B+ programme was implemented in 
the country.  
 
 
3.4.2.4 Sampling technique 
Purposive sampling was used for this study. Polit and Beck (2014:285) state that 
purposeful sampling is when the researchers deliberately choose the cases or types of 
cases that will best contribute to the study. The Public Health Unit in Manzini was 
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selected purposively for this study because it was one of the pilot sites for PMTCT 
Option B+ programme implementation. All HIV positive pregnant mothers who had 
enrolled on the PMTCT Option B+ programme were identified by the nurses at the 
antenatal department when coming to the facility for antenatal check-up, and those who 
agreed to participate in the study were interviewed. Sample frame is the list or some 
representation of the study population, either of individuals or groups, or the list of all 
the elements in the population, from which the sample is drawn (Joubert & Ehrlich 
2012:95; Polit & Beck 2012:742). All HIV positive pregnant mothers who had enrolled in 
the PMTCT Option B+ programme were identified for the study using their antenatal 
cards. 
 
3.4.3 Ethical issues related to sampling 
 
Ethics refers to a system of moral values that is concerned with the degree to which 
research procedures adhere to professional, legal, and social obligations to the study 
participants (Polit & Beck 2012:727).  
 
The study took place in a Public Health Unit in Manzini where eligible participants were 
recruited during their antenatal care clinic attendance. The researcher provided 
information about the study after the senior nurse facilitated the introduction process. 
HIV positive pregnant mothers who had enrolled on PMTCT Option B+ programme 
were informed that the study was not part of antenatal services, but was voluntary for 
those willing to participate, and that they had the right to decline participation. They 
were also informed that they were even allowed to withdraw any time from the study 
and that this would not affect PMTCT Option B+ programme services offered to them. 
Also refusal to participate in the study was not going to affect health care services they 
had come for in any way. Informed consent was obtained from participants and was 
written in English and translated in siSwati. The HIV positive pregnant mothers were 
also informed that the study might be used for scientific purposes and may be 
published.  
 
3.4.4 Data collection 
 
Data collection is the gathering of information to address the research problem (Polit & 
Beck 2012:725). Data collecting instruments are tools used to collect data in a study 
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which may include interviews, and focus group discussions (AIS3704 Only study guide 
2008:81). According to Burns and Groove (2009:510), data in qualitative research are 
collected by means of verbal responses from individuals and organized into categories 
that describe the phenomenon being studied through data analysis. In this study, the 
researcher used in-depth one-to-one, semi-structured interviews to collect data from 
HIV positive pregnant mothers who enrolled on the PMTCT Option B+ programme.  
 
3.4.3.1 Data collection procedure and method 
 
Semi-structured interviews were conducted in December 2015. In the semi-structured 
method the researcher wanted to be sure that a specific set of topics was covered in the 
interviews. The researcher prepared an interview guide, and the interview encouraged 
the participants to talk freely about all the topics on the guide, and to tell stories in their 
own words. This technique ensured that researchers will obtain all the information 
required and gives participants freedom to provide as many answers as they wish (Polit 
& Beck 2012:537).  
 
The permission to conduct this research project was granted by the University of South 
Africa’s (UNISA) Department of Health Studies Higher Degrees Committee in February 
2015 (Annexure A) and the Swaziland Ministry of Health Research Ethics Committee on 
24th November 2015 (Annexure D).Permission to conduct the research was also 
requested from sister-in-charge at the Public Health (Annexure B). Data were collected 
over one month in December 2015. The researcher was introduced to the antenatal 
clinic staff by the nurse manager of Public Health Unit in Manzini and all the necessary 
protocols were observed. 
  
The interview guide was developed for this study in both English and siSwati, using 
research objectives and questions as the guidelines. The developed interview guide 
consisted of open-ended questions that allowed the participants to freely describe their 
perceptions regarding PMTCT Option B+ programme. The Public Health Unit in Manzini 
was visited in the mornings at the stipulated antenatal care services dates. The 
antenatal care unit nurses facilitated the process by introducing the researcher and 
informing all HIV positive pregnant mothers enrolled on the PMTCT Option B+ 
programme about the study. Interviews were conducted in the mornings and a room 
was prepared for the interviews to allow privacy with the participants. 
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The researcher was able to establish rapport with participants through good verbal 
communication and warm welcome. Consent was obtained from the participants, who 
were able to share their feelings and views. The interviews were conducted in the 
language spoken by the participants, which is siSwati. A tape recorder was used to 
record the interview after obtaining permission from the participants. As HIV is a 
sensitive issue, the researcher made sure that the room where interviews were taking 
place has a “DO NOT DISTURB” sign on the door and all heath care workers were 
notified of the session so that nobody enters the interview room.  Each interview record 
was labeled with an assigned code according to the date the interview took place. The 
interview periods ranged between 30 minutes and 40 minutes per participant.  The 
research assistant who was experienced and knowledgeable about research was 
recruited by the researcher. Field notes were written during the interview by the 
research assistant. Both verbal and none verbal responses were written down. Data 
were collected until the data saturation was reached at the 17th participant.  
 
3.4.3.2 Development and testing of data collection instrument 
 
A pilot study is a test run of aspects of the main study. It requires an in-depth look at the 
interview guide with the aim of improving its quality (Joubert & Ehrlich 2012:116). The 
interview guide was reviewed by the supervisor and the University of South Africa’s 
Health Studies Higher Degrees Committee. The interview guide was also reviewed by 
the Swaziland Ministry of Health Ethical Committee. The nurse manager and nurses 
working at the Public Health Clinic involved in providing the PMTCT Option B+ 
programme services were also given the guide to review.  
 
A pilot study of the interview guide was conducted with three HIV positive pregnant 
mothers enrolled on the PMTCT Option B+ programme as they had comparable 
characteristics with the participants to be studied. The researcher recorded words and 
sentences that were not clear and questions that required explanation. The participants’ 
perceptions about the interview guide questions were captured. The feedback was 
integrated into the final version of the data collection instrument.  
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3.4.3.3 Characteristics of the interview guide 
 
The interview guide had three sections. The first section consisted of the information 
about the biographical data i.e. age, ethnic group, home language, area of residence, 
marital status, educational level, employment status, number of children, obstetric 
history, and religion. The second section reflected interview identification that is, 
interview number, date of interview and time of interview. The third section contained a 
key statement (Tell me about your perceptions of being enrolled on the PMTCT Option 
B+ programme in the Public Health Unit):  and probing questions (What do you 
understand about PMTCT Option B+ programme? What is your perception of the care 
that you receive at the antenatal clinic? How effective is the PMTCT Option B+ 
programme?, What challenges you have of taking ARV treatment?,  What information 
do you need with regard to PMTCT Option B+ programme?, How can the nurses in the 
Public Health Unit assist you as a HIV positive pregnant mother and enrolled on the 
PMTCT Option B+ programme?). 
 
 
3.4.5 Ethical consideration related to data collection 
 
Protecting the research participants was ensured by respecting the principles on which 
standards of research are based which are beneficence, respect for human dignity and 
justice (Joubert & Ehrlich 2012:32). 
 
Beneficence imposes a duty on researcher to minimize harm and maximize benefits. It 
requires acting in ways that will benefit and not cause harm (Polit & Beck 2012:152). 
Ethical standards were used in the study. Participants were informed that they were not 
forced to answer any questions and this protected them from emotional harm. Approval 
to conduct the study was obtained from the Higher Degrees Committee of the 
Department of the Health Studies at UNISA. Permission to conduct the study was also 
obtained from the Swaziland Ministry of Health Ethical Committee and the Public Health 
Unit in Manzini where data were collected.  
 
Respect for human dignity includes right to self-determination and the right to full 
disclosure. People should be treated as autonomous agents, capable of controlling their 
own actions and disclosure. Autonomy is closely linked with respect for an individual’s 
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free will and includes the right to make choices about issues affecting one’s being. Full 
disclosure means that the researcher has fully described the nature of the study, the 
person’s right to refuse participation, the researcher‘s responsibilities, and the likely 
risks and benefits (Polit & Beck 2012:154; Andrews & Boyle 2012:407). Participants 
signed consent forms after the nature, purpose, and significance of the study were 
explained before commencing with the interview sessions (Annexure E). No coercion 
was used when asked to participate in the study, but respondents were asked to 
participate voluntarily. They were informed that field notes were written and that a tape 
recorder was used during the interview to capture the proceedings of the interview 
sessions.  
 
Justice includes participants’ right to fair treatment and their right to privacy (Polit & 
Beck 2012:155). Participant selection was based on study requirements and not on 
group vulnerability. Participants were informed that they had the right to withdraw from 
the study at any stage they wished to and that participation was voluntary. Participants 
were assured of confidentiality and anonymity as their names were not used as only 
codes were used to protect their privacy. 
 
Scientific integrity is demonstrated by on-going self-reflection and self-scrutiny to 
ensure that interpretations are valid and grounded in the data (Polit & Beck 2012:586). 
The scientific integrity of the researcher must be indisputable and incontrovertible (Pera 
&Van Tonder 2011:340). The procedures and expectations were explained to the 
participants in language that they understood and transparency was maintained. 
Nothing was hidden to participants. Honesty with participants was maintained; the 
researcher did not mention names of participants and what they had agreed on with the 
participants, and interpretation of data was grounded on data collected. 
 
3.4.6 Data analysis 
 
Bogdan and Bilken (1982:145) define qualitative data analysis as “working with data 
[which are textual, non-numerical and unstructured], organizing it , breaking it into 
meaningful units, synthesizing it, searching for patterns, discovering what is important 
and what is to be learned and deciding what to tell others”. The purpose of data analysis 
is to organize, provide, structure to, and elicit meaning of data (Polit & Beck 2012:556). 
In this study, data were analysed using the computer and data from tape recorder were 
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transcribed then transferred to the computer. The notes taken during interviews were 
also transferred to the computer. Data were analysed using the following step-wise 
format proposed by Tesch (Creswell 2014:209). 
 
Data were organized and prepared. The researcher read through all the transcripts 
carefully and made notes of some ideas as they came to mind. All underlying meanings 
were noted down; and all similar topics were put together and grouped into major topics. 
The entire data file was entered into the computer. Reading of the data carefully helped 
to ensure that the researcher was familiar with the data. Then all the topics were 
assigned an abbreviated and identifiable code, written next to the data segments that 
corresponded with the codes. Next step was to find the most descriptive wording for the 
topics and were turned into themes and categories; topics that related to each other 
were grouped together to reduce the total list of themes/categories. Then the codes 
were alphabetized after the final decision on the abbreviation for each theme/category. 
Using the cut and paste method, data material belonging to each theme/category were 
assembled in one place and preliminary analysis was done. This was followed by 
interpreting and reporting the research findings.  
 
3.5 MEASURES TO ENSURE TRUSTWORTHNESS 
 
Trustworthiness is the degree of confidence qualitative researchers have in their data, 
assessed using the criteria of credibility, dependability, conformability, and 
transferability (Polit & Beck 2012:745). In this study, trustworthiness was enhanced 
using these criteria as suggested by Lincoln and Guba (1985) cited in Polit and Beck 
(2012:584). 
 
Credibility refers to confidence in the truth of the data and interpretation of them (Polit 
& Beck 2012:585). It was enhanced in the study by checking with participants if 
instructions were clear, paraphrasing to clarify meaning, also by using different methods 
of data collection instruments which were a tape recorder and field notes.  
 
Dependability refers to the stability (reliability) of data over time and conditions (Polit & 
Beck 2012:585). Dependability was enhanced in the study by use of valid data 
collecting tools, which were available and meet the standard of qualitative research. The 
participants were willing to participate in the study and were assured that confidentiality 
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was maintained by the use of codes and also a tape recorder was used to ensure that 
data were reliable. 
 
Conformability refers to objectivity, that is, the potential for congruence between two or 
more dependent people about the data’s accuracy, relevance, or meaning (Polit & Beck 
2012:585). In this, study conformability was enhanced by submitting the data to be 
analyzed by an independent coder to confirm the researcher’s findings and also by the 
use of a tape recorder, which assisted during the interview to collect the data. 
 
Transferability refers to potential for extrapolation, that is, the extent to which the 
findings can be transferred to or have applicability in other settings or groups (Polit 
&Beck 2012:585). The research findings will be forwarded to the Swaziland Ministry of 
Heath to be used in improving the implemented PMTCT Option B+ programme.  
 
Authenticity refers to the extent to which researchers fairly and faithfully show a range 
of realities. Authenticity emerges in a report when it conveys the feeling tone of 
participants’ lives as they are lived (Polit &Beck 2012:585). Therefore, the researcher 
demonstrated the feeling tone of the participants’ lives as they were lived by conducting 
the research within participants’ natural and everyday environments. 
 
3.5 CONCLUSION 
 
This chapter discussed research design and method used to conduct the study in order 
to explore and describe the perceptions of HIV positive pregnant mothers regarding 
PMTCT Option B+ programme. It also discussed sampling, data collection method and 
data analysis. Ethical issues related to sampling and data collection were also 
discussed. 
 
Chapter 4 addresses analysis, presentation and description of research findings.
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CHAPTER 4 
 
DATA ANALYSIS, PRESENTATIONS AND DESCRIPTION OF 
RESEARCH FINDINGS 
 
4.1 INTRODUCTION 
 
Data analysis involves arranging data or information gathered into meaningful units. The 
purpose of data analysis is to organize, provide, structure and elicit meaning of data 
(Polit & Beck 2012:556). This chapter presents the data collected from HIV positive 
pregnant mothers who had enrolled on the PMTCT Option B+ programme at a Public 
Health Unit in December 2015.The findings of the study are presented in this chapter 
and includes perceptions of HIV positive pregnant mothers with regard to PMTCT 
Option B+ programme. The findings in this chapter will assist in serving the purpose of 
the study which was to explore and describe the perceptions of the HIV positive 
pregnant mothers regarding the PMTCT Option B+ programme in order to identify and 
describe gaps; and also help the Swaziland government address these gaps. 
 
4.2 DATA MANAGEMENT AND ANALYSIS 
 
A tape recorder was used to collect the data after obtaining permission from the 
participants. Data were collected in Siswati; and field notes including observed 
behaviour and reflections were also taken and recorded. The notes taken during the 
interviews and data from tape recorder were transferred into the computer. Data were 
analysed using the following step-wise format as proposed by Tesch (Creswell 
2014:209). 
 
The next step was to find the most descriptive wording for the topics and were turned 
into themes and categories; topics that related to each other were grouped together to 
reduce the total list of themes/categories. Then the codes were alphabetized after the 
final decision on the abbreviation for each theme/category. Using the cut and paste 
method, data material belonging to each theme/category were assembled in one place 
and preliminary analysis was done. This was followed by interpreting and reporting the 
research findings.  
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4.3 DEMOGRAPHIC CHARACTERISTICS OF THE PARTICIPANTS 
 
4.3.1 Age distribution of participants 
 
The following graph presents the age distribution of the participants: 
 
 
 
Figure 4.1 Age distribution of participants (N=17) 
 
The age distribution in the above graph met the inclusion criteria for age of the 
participants, as it states that participants who had to be part to the study must be 
between the ages of 18 to 40 years. This is because the National constitution states that 
any person below the age of 18 years is a child (Swaziland Ministry of Health 2014:46). 
The age distribution is very important as clients above the age of 12 years in Swaziland 
are able to assent consent for HIV testing. The Child protection Act of 2012 states that 
“anyone 12 years and above is able to give full consent for health care services. This 
includes consent for HIV testing” (The Swaziland Government 2012:S13; Swaziland 
Ministry of Health 2014:46) 
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4.3.2 Residential areas of participants 
 
 
Figure 4.2 Areas of residence of participants 
 
Figure 4.2 shows the area of residence for the participants. One of the objectives of the 
study was to explore and describe the perceptions of the HIV positive pregnant mothers 
with regard to PMTCT Option B+ programme at a Public Health Unit at Manzini region. 
Therefore, areas of residence for the participants are located in the Manzini region near 
the facility where the study is conducted. 
 
4.3.3 Level of education of the pregnant women 
 
Figure 4.3   Level of education of pregnant women (N=17) 
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The figure above shows the level of education of the pregnant women who were 
participants in the study. The findings show that 23.5% (4) of the pregnant women had 
enrolled in a primary school, 41.5% (7) with secondary school, and 35% (6) had 
completed their higher level of education. The level of education is important to assess 
because people who have received lesser education may have less health related 
knowledge, and educational level is an indirect indicator of population health status 
(Clark 2008:355). These participants needed to enroll on PMTCT training whereby there 
is a great need for them to be educated about this programme and ART treatment and 
also the importance of adherence to this treatment so that they can give birth to 
healthier babies and HIV free generation. With a lower level of education among the 
pregnant mothers, the health care workers have an important role of providing health 
education to ensure that the pregnant mothers are more knowledgeable so that they are 
able to adhere on demands of this programme. 
 
 
4.3.4 Employment status of the pregnant women linked to major source of 
income 
 
 
Figure4.4 Employment status of participants (N=17) 
 
  
4, 24%
13, 76%
Working
Yes No
  
35 
4.3.5 Type of employment status of participants 
 
Those that responded affirmatively to working were further requested to state the type 
of work they do and their responses were as follows: 
 
 
Figure 4.5 Type of employment status of participants (N=4) 
 
4.3.6 Major source of income 
 
All the participants were asked what their major sources of income were and from the 
total of seventeen, only four had no source of income. The rest gave the following 
responses: 
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Figure 4.6 Major source of income of participants (N=17) 
 
The findings in Figure 4.4 show that four of the participants were employed and thirteen 
participants were not employed. Among the employed participants one is employed 
fulltime, one employed part time and two employed seasonally. Furthermore, for all 
participants source of income showed there were those who were self- employed, full-
time employed, part-time employed, other and none. Worth mentioning is that amongst 
those that had no source of income, mostly cited getting income from either their 
partners or spouses. In this study the employment status for participants was assessed 
because this had the potential to impact on the feeding options they chose for their 
babies as it is part of the PMTCT programme. In addition, the source of income for the 
participants might influence their ability to provide for basic necessities and to gain 
access to health care services as they might lack money for transport to attend 
antenatal care visits on stipulated dates and refill for the ART treatment. 
 
The findings in Figure 4.6 also indicated that there were more numbers of unemployed 
participants with limited source of income and therefore, will be limited to choose 
exclusively breast feeding option in accordance with national guidelines on infant and 
young child feeding. As a global public health recommendation, infants should be 
exclusively breasted for the first six months of life to achieve optimal growth, 
development and health (Swaziland Ministry of Health 2010b:19; Ministry of Health, 
King of Swaziland2010a:19). The health care workers should motivate and educate 
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pregnant mothers on the benefits and management of exclusively breastfeeding to 
reduce mother-to-child transmission of HIV, because HIV can be transmitted from 
mother to her infant during breastfeeding (Swaziland Ministry of Health:2014:6). 
 
4.3.7 Marital status of participants linked to status relationship 
 
 
Figure 4.7 Marital status of participants (N=17) 
 
The participants were further asked to state whether they lived with their spouses or 
partners and these were their responses. 
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4.3.8 Living arrangements of participants 
 
 
Figure 4.8 Living arrangements of participants (N=17) 
 
The findings in Figure 4.7 show that ten participants were married and seven not 
married.  Figure 4.8 shows the living arrangements of the participants, four participants 
were living with their partners, five with their husbands, seven have their partners or 
husbands staying elsewhere and only one participant had not stated. Participant’s 
marital status was assessed because these women need support from partners once 
they start ART treatment. Health care workers should encourage HIV positive pregnant 
mothers to maintain good and healthy relationship at home in order to enhance the 
quality of their lives. Health care workers must also encourage these HIV positive 
pregnant mothers to disclose their status to partners as disclosure enhances the 
opportunities for HIV infected person to receive support in obtaining proper medical care 
and treatment. One benefit of disclosure is to assist the HIV infected individual in taking 
medication properly as she would be able to take medication openly and acknowledge 
her HIV status (Swaziland Ministry of Health 2014:35). 
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4.3.9 Pregnancy history of participants in accordance to live births and children 
alive 
 
 
Figure 4.9 Pregnancy history of participants (N=17) 
 
The above graph indicates that six of the participants were pregnant for the first time 
and of these only three managed to deliver. Four respondents were on their second 
pregnancy and of these six babies were delivered and were alive. Two were pregnant 
for the third time, and the other two were pregnant for the fourth time, one is pregnant 
for the fifth time, one also pregnant for the sixth time, and only one on her seventh 
pregnancy.  
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4.3.10 Testing of children 
 
 
Figure 4.10 Testing of children (N=17) 
 
A majority of the respondents (10) alluded to have tested their children for HIV out of the 
total number of women interviewed. There were women who did not have children thus 
no test history information was required from them. Worth noting is the four women who 
decided not to test their children and this is worrisome.  
 
A question was asked on the number of children that were tested for HIV and turned out 
to be positive in the history of these respondents and a total of five respondents had 
children who were HIV positive. Three of these women had one child positive, one 
respondent having three HIV positive children and another woman with four HIV positive 
children.  
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4.3.11 HIV testing history in accordance with reason for testing 
 
 
Figure 4.11 Testing history of pregnant women in accordance with  
reason for testing (N=17) 
 
The majority of these respondents first tested HIV positive in 2015. These respondents 
were tested during pregnancy and represented by 13, 3% wanted to know their HIV 
status, and one participant tested while hospitalized. According to the PMTCT 
guidelines, every pregnant woman must do HIV testing during pregnancy as the PMTCT 
is a highly effective intervention which ensures that an HIV infected mother does not 
pass the infection to her child (Swaziland Ministry of Health 2010a:4). For this 
programme to be effective it is important that every pregnant mother knows her HIV 
status. The midwives, therefore, have a great responsibility to ensure that every 
pregnant woman does an HIV test. The participants testing history indicated that 11 of 
the participants were with new infection as they tested during this pregnancy, while the 
six came for antenatal care services with known HIV status as one tested during 
hospitalisation and three of them tested because they wanted to know their HIV status. 
The nurse midwives and counsellors have a responsibility to educate HIV positive 
pregnant mothers about the PMTCT programme and on-going counselling is needed to 
ensure that Swazilandthe programme is effective. Pregnant women need to be 
empowered with regard to PMTCT Option B+ programme as all these women have no 
experience on this programme as it was recently implemented in the country. 
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Table 4.1 Themes and sub-themes of HIV positive pregnant mothers 
 
THEMES SUB-THEMES 
1.Perceptions of respondents on being 
enrolled on the PMTCT Option B+ programme 
 
1.1 ART boosts the immune system and 
prevents opportunistic infections so that 
they may not live longer 
1.2 ART increases CD4 count 
1.3 Prevention of mother-to-child transmission 
of HIV 
2.Understanding about PMTCT Option B+ 
programme and information needed with 
regard to PMTCT Option B+ programme  
 
2.1 Life-long ART is initiated immediately 
regardless of CD4 count and PMTCT is 
done during pregnancy, delivery and 
breastfeeding 
ART Prolongs life span 
2.2 Importance of drugs and balance diet 
2.3 Assistance with  adherence 
 
3.Perceptions with the care received from the 
nurses and their assistance on PMTCT Option 
B+ programme 
 
3.1 Friendly and approachable nurses 
3.2 Assistance in Health education about 
PMTCT Option B+ programme and effects 
of ART drugs 
3.3 Assistance in disclosure, adherence and 
ongoing counselling 
 
4.Effectiveness of the PMTCT Option B+ 
programme 
 
4.1 Prolongs life span 
4.2 Importance of adherence to treatment 
4.3 Prevention of mother-to-child transmission 
5.Challenges of taking ARVs 5.1 Disclosure and Discrimination 
5.2 Partner testing 
5.3 Side effects of ART  
 
 
4.4 PERCEPTIONS OF HIV POSITIVE PREGNANT MOTHERS WITH REGARD TO 
PMTCT OPTION B+ PROGRAMME 
 
 
The themes indicated in Table 4.1above emerged during data collection and analysis 
based on the objectives of the study. The themes were: Perceptions of respondents on 
being enrolled in the PMTCT Option B+ programme, Understanding about PMTCT 
Option B+ programme and information needed with regard to PMTCT Option B+ 
programme, Perceptions with the care received from the nurses and their assistance on 
PMTCT Option B+ programme, Effectiveness of the PMTCT Option B+ programme and 
Challenges of taking ARVs. 
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4.4.1 Theme 1: Perceptions of respondents on being enrolled on the PMTCT 
Option B+ programme 
 
One of the objectives of the study was to explore and describe the perceptions of the 
HIV positive pregnant mothers with regard to PMTCT Option B+ programme. Swaziland 
had adopted PMTCT Option A since 2003 and with the increase number of children 
testing HIV positive between 2011 and 2014 (USAID & IHM 2014:16), the Swaziland 
Ministry of Health started piloting PMTCT Option B+ programme since 2015, thus the 
study was done to explore and describe the perceptions of the HIV positive mothers 
regarding the recently piloted PMTCT Option B+ programme. The participants’ 
demographic characteristics regarding testing history shows that 11 of the participants 
were with new infection as they tested during this pregnancy, while the six came for 
antenatal care services with known HIV status as one tested during hospitalisation and 
three of them tested because they wanted to know their HIV status. This information 
indicates that majority of the participants had known their HIV status during the present 
pregnancy and were enrolled to the PMTCT programme.Therefore, it was very 
important to ask the HIV positive pregnant mothers about their perceptions towards this 
programme.  
 
Sub-theme 1.1: ART boosts the immune system and prevents opportunistic infections 
so that they may live longer 
 
When participants were asked about their perceptions of being enrolled on PMTCT 
Option B+ programme they gave the following responses: 
“I will always look healthy without any opportunistic infection and will be able to 
raise my child healthy.” (Participant 3). 
 
“The medication I am taking will help me to be strong so that I cannot fall sick and 
I will be able to raise my child.” (Participant 7). 
 
“I can now live longer together with my baby as the treatment suppresses the 
virus so that I cannot pass it to my baby and my partner.” (Participant 9). 
 
“The treatment will prolong my life and I will be able to raise my child.” 
(Participant 12). 
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“This programme will prolong our lives without infecting our children” (Participant 
13). 
“I w ill be able to live longer for more years provided I adhere to treatment.” 
(Participant 14). 
 
Maputle and Jali (2008:45) contend that for PMTCT interventions to be effective, every 
individual woman, more so those of child bearing age, needs to be empowered and 
updated with knowledge concerning HIV infection, the associated risks of transmission 
to their children, as well as the available options that will help them counter the risk of 
HIV transmission to their child. 
 
Sub-theme 1.2: ART increases CD4 count and boost immune system 
 
Furthermore, the participants reported the following with regard to CD4 count and ART: 
 
“Yes, a person taking ARVs is not seen that he or she is sick, he or she looks 
healthy like everybody. The tablets suppress the HIV then the CD4 count 
increases and then you are not affected by any diseases.” (Participant 2). 
 
“ARVs and adherence to treatmentwill help to boost my immune system and will 
be able to live longer.” (Participant 9) 
 
“Yes, I was sick before I started the treatment, with general body malaise, and 
since I started taking them I feel very healthy and I have lot of 
energy.”(Participant 15). 
 
According to Baylor International Paediatric Aids Initiative (2010:46), HIV infection 
severely affects the CD4 cell and when a patient begins ART, the CD4 count will 
increase. This is a reflection of the immune system’s improved ability to fight infection.  
 
 
Sub-theme1.3: Prevention of mother-to-child transmission of HIV 
 
Additionally, participants perceived this programme as preventing of mother-to-child 
transmission of HIV as supported by the following extracts: 
 
“It is helping me because I will be able to protect my child from getting HIV 
infection.” (Participant 1). 
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            “It will protect my unborn child from being infected.” (Participants 2, 4, 6). 
 
“Whether you are sick or not you take your ARVs so that your baby may not be 
infected.” (Participant 8). 
 
“ART suppress HI virus so that it cannot pass to the baby during pregnancy, 
delivery and breastfeeding.” (Participant 10). 
 
“It will increase my CD4 count and will help prevent my child from being infected.” 
(Participant 15). 
 
“It is good to protect or prevent one from giving birth to a HIV positive baby.” 
(Participant 16). 
 
Ochigbo (2013:28), attests that HIV infected women in Botswana were consistent in 
taking their ARV drugs as directed. They all believed that anti-HIV medication prevent 
HIV to child if well taken. According to Bobb (2012:1), women must have access to 
education and knowledge as well as being empowered to protect them from HIV. 
 
The third approach in implementing PMTCT is prevention of mother-to-child 
transmission (PMTCT) among HIV-positive pregnant women (Ministry of Health, 
Kingdom of Swaziland 2015:93). 
 
Other participants reported that ART is just like taking any ordinary tablets and that they 
did not have stress in taking them, as explained by one participant: 
 
“Many people are HIV positive and I am one of them and I am not seen by 
anybody that I am on ART. Taking  ARV’s’ is like taking any ordinary tablets, just 
like I was taking family planning tablets or pain tablets, and I do not have stress in 
taking them.” (Participant 8). 
  
Without ART treatment, people living with HIV can become ill because of the damage 
HIV does to the immune system. With HIV treatment many people living with HIV are 
living just as long as people who do not have HIV (May, Gompels & Sabin 2012:1).  
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4.4.2 Theme 2: Understanding about PMTCT Option B+ programme and 
information needed with regard to PMTCT Option B+ programme 
 
Participants responded that they understood that they had to take one tablet at a time, 
and are taken once every day, and for them to be effective they are not mixed with 
some traditional herbals.  
 
Sub-theme 2.1:Life-long ART is initiated immediately regardless of CD4 count and 
PMTCT is done during pregnancy, delivery and breastfeeding.  
 
Participants also understood that patients should start ART immediately when they are 
diagnosed with HIV and once they start taking them they should continue for the rest of 
their life. In addition, the participants also understood that: 
 
“CD4 count is no longer considered like before and treatment is taken even if 
your CD4 count is high.” (Participant 16). 
 
“All pregnant mothers should start ART treatment to increase their CD4 count.” 
(Participant 1). 
 
“Mothers should start medication early during pregnancy to reduce transmission 
rate of HIV to the baby while pregnant.” (Participant 2).  
 
“You have to start ART immediately during pregnancy to avoid HIV transmission 
to the baby regardless of the CD4 count.” (Participant 3). 
 
“The tablet is taken once and the CD4 count is no longer considered, even if your 
CD4 count is high you are initiated on ART immediately. The tablets do not 
change the structure of your body like before and you do not have to stop taking 
them even after delivery as they are a lifelong treatment.” (Participant 13).  
 
The participants understanding is also supported by the Swaziland PMTCT guidelines 
where it emphasises that “all pregnant HIV-positive women should be initiated on 
lifelong ART regardless of CD4 count and /or WHO clinical stage, preferably at the first 
ANC visit, while maintaining on-going counselling” (Ministry of Health, Kingdom of 
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Swaziland 2015:98). With PMTCT Option B+ programme, all pregnant women living 
with HIV are offered lifelong ART, regardless of their CD4 count.  (UNICEF 2012:2). 
 
Participants also stated that they understood that PMTCT is done during pregnancy, 
delivery and breastfeeding, thus the treatment is taken to prevent mother-to-child 
transmission throughout all the stages. According to participants:  
 
“You no longer stop taking the ARV medication after delivery like before, but you 
continue taking them for the rest of your life.” (Participant 14). 
 
“The baby is prevented from being infected during pregnancy, breastfeeding, and 
delivery. That’s why you no longer stop the treatment even after delivery.” 
(Participant 1). 
 
“I think it shall help my unborn baby not to get the virus.” (Participant 7). 
 
“The treatment will protect my baby during pregnancy and suppress the HIV so 
that I will not fall sick.” (Participant 6). 
 
The participants understanding is supported by the U.S Department of Health and 
Human Services (2017:1) which stated that pregnant women who are HIV positive 
receive ART medication during pregnancy, delivery and breast feeding to prevent 
mother-to-child transmission of HIV. 
 
Sub-theme 2.2: Importance of drugs and balance diet 
 
When a pregnant HIV infected woman receives adequate medical care early and takes 
antiviral medications regularly during her pregnancy, the chance that she will transmit 
HIV to her unborn child is dramatically reduced.  It is important that any HIV positive 
pregnant woman begins prenatal care as soon as possible in order to take full 
advantage of such availability of treatment. The sooner a mother receives treatment, the 
greater the likelihood that her child will not be HIV infected. Before the birth of her child, 
antiviral treatments administered on the mother during pregnancy could help prevent 
HIV transmission to the child. At the time of birth, antiviral medications could be given to 
both the mother and the newborn child to lower the risk of HIV transmission that could 
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occur during the birth process which exposes the newborn child to the mother’s blood 
and fluids (Dowshen-Atanda 2012:2). 
 
When participants were asked about the importance of ART drugs they stated that: 
 
“It prolongs life for the mother and prevents HIV transmission to the baby.” 
(Participant 5). 
 
“Not only the baby will be prevented from HIV infection, but also my partner will 
be prevented from HIV if I take ART.” (Participant 7).   
 
“Adherence to the treatment will boost my immune system and will be able to 
live longer.” (Participant 9) 
 
The participants’ responses concur with the Swaziland National AIDS Programme 
(2014:10), which states that clinical benefits of ART are to decrease opportunistic 
infections, maintain or reverse immune system damage and prolong survival. One of the 
benefits of ART is to reduce transmission of HIV within discordant couples, from mother 
to child, and to new partners (Swaziland National Aids Programme 2014:10). This 
statement is also supported by Ebuy, Yebyo & Almayehu (2014:128) who stated that it 
is possible to reduce risk of HIV transmission from mother to baby if mother takes 
PMTCT drugs. 
 
One participant emphasized the importance of taking the ART tablet as a prescribed 
dosage and taking it daily as she stated that: 
 
“ART tablets are taken as one tablet, same time, everyday and they are not 
mixed with some traditional herbs. Whether you are sick or not you must take 
your ARVs so that your baby may not be infected.” (Participant 8).  
 
As ARV medications become more widely available in areas where traditional healers 
work, practices such as mixing low doses of ARV drugs into herbal remedies would 
harm patients by leading to the development of viral resistance (Baylor International 
Pediatric AIDS Initiative 2010:304). Many herbs and supplements contain undeclared 
pharmaceutical drugs, heavy metals and other contaminants. Therefore health care 
workers must inform patients about known treatment related risks and must be aware 
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that unknown toxic effects or interactions may exist (Baylor International Paediatric 
AIDS Initiative 2010:305). 
 
Some participants responded by saying that they needed to know why some people 
took the medication once whilst others took it twice. They also wanted to know the 
importance of co-trimoxazole tablets, and responded thus:  
 
“I need to know why others had to take the tablets once whilst others take them 
twice, and it is important to always take co-trimoxazole tablets.” (Participant 2). 
 
“I need to know what the importance of co-trimoxazole tablets is.” (Participant 3). 
 
Others also stated the importance of a balanced diet as it is needed for ARV treatment 
to be more effective. Participants seven and seventeen had this to say:  
 
“I will live longer if I take the ARV treatment as prescribed, and also eat a 
balanced diet.” (Participant 7). 
 
“It is important to eat balanced diet for the ART treatment to be effective and also 
take the medication as prescribed and at the right time.” (Participant 17). 
 
HIV affects nutrition by decreasing food consumption, impairing nutrients absorption 
and causing changes in metabolism. Poor nutritional status can speed up progression 
of HIV disease (Sellers 2014:714). Economic issues leading to inadequate nutrient 
intake are frequent contributors to malnutrition in many settings (Baylor International 
Paediatric AIDS Initiative 2010:287).  HIV-positive pregnant women are vulnerable to 
nutrient deficiencies mainly due to increase nutrient requirements associated with HIV 
and demands of pregnancy (Sellers 2014:714). Therefore, HIV increases the risk of 
maternal malnutrition, which in turn increases the risk of mother to child transmission, 
and ultimately increases maternal and foetal morbidity and mortality (Sellers 2014:714). 
According to the Ministry of Health, Kingdom of Swaziland (2010a:41), the needs of a 
pregnant woman are an adequate nutritious diet. Poor maternal nutrition may also affect 
transmission of HIV to the infant (Ministry of Health, Kingdom of Swaziland 
(2010b:115).Improving nutrition prior to pregnancy should be the main goal to minimize 
the impact of HIV on the pregnancy outcome (Sellers 2014:714). 
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Sub-theme 2.3: Assistance with adherence 
 
Other participants responded by saying that they needed information on what they could 
be assisted with regarding the challenge of failure to adhere to treatment and they also 
need to know what happens if they forget to take the medication for days. The 
participants indicated the following: 
 
“I need to know what the effects of ART on my body are especially if I am not adhering to  
treatment.”  (Participant 14). 
 
“I need to be assisted on adherence to treatment.” (Participant 15). 
 
HIV positive pregnant mothers who repeatedly face adherence challenges must be 
provided with routine counselling and follow-up. Ebuy et al (2014:1) believed that proper 
counselling and patient follow up are advantages of adherence to the drugs. The client 
must be traced consistently to ensure overcoming of adherence barriers. 
 
The PMTCT guidelines: Ministry of Health, Kingdom of Swaziland (2015:90), encourage 
nurses to assist clients who repeatedly face adherence challenges by:  
 
 Providing one-on-one counselling to try to understand what is happening in the 
person’s life and the reasons behind non-adherence. 
 Encourage client to use treatment supporter and join support groups. 
 Routinely document and trace clients who fail to return to clinic for appointments  
 
There are those who responded that they did not need any further information about the 
programme since they had already been taught by the nurses on their first clinic visit. 
They thought that they already had enough knowledge and enough information about 
PMTCT Option B+ programme as their responses were: 
 
“The counselling I had was satisfactory.” (Participant 5). 
 
“I do have knowledge on PMTCT Option B.” (Participant 7). 
 
“The nurses taught me everything I need.” (Participant 8). 
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“I think the nurses health education was of great assistance because I now know 
on how to prevent my child from being infected.” (Participant 9). 
 
“I do not need any additional information because they taught me everything I 
need to know.” (Participant 10). 
 
“None for now because I think the nurses gave me enough information during the 
counselling session.” (Participant 17). 
 
4.4.3Theme 3: Perceptions with the care received from the nurses and their 
assistance on PMTCT Option B+ programme 
 
The respondents highly praised the care they receive from the nurses at the Public 
Health Unit and their responses indicate that there is good nurse patient relationship.  
 
Sub-theme 3.1: Friendly and approachable nurses 
 
Participants expressed their happiness and gave the following responses when asked 
about their perceptions with care they receive from the nurses:  
 
“The nurses are always so caring and this is my third pregnancy in this facility, 
and I am satisfied.” (Participant 3). 
 
“They welcomed me back even when I defaulted and told me the disadvantages 
of stopping taking ART.” (Participant 8). 
 
“I am taken good care of since I started attending the facility.” (Participant13). 
 
“The nurses are so caring and I'm satisfied and I make sure I do everything they 
advised me about.” (Participant 15).  
 
“The nurses are good and took good care of me and my unborn baby even when 
I return before my due date they attended me.” (Participant 12). 
 
“They are good as they manage to explain and take care of us.” (Participant 2). 
 
“They are so caring and faster especially at ART department.” (Participant 6). 
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“They are good because even when we are sick we get cured and not pay even a 
cent.” (Participant9). 
 
“The nurses are friendly and approachable and the pregnant mothers are free to 
ask questions and interact with them.” (Participant 4). 
 
One respondent said that: 
 
“They are good; we are not subjected to abuse like in other facilities and that is 
why we come at Sobhuza.” (Participant 14).  
 
The researcher was therefore of the opinion that a study be conducted at the health 
care facilities to investigate PMTCT Option B+ programme received by the clients. For 
services rendered by nurses to be effective nurses must have good attitude towards 
patients. Since nurses work very closely with the patients, a lack of sensitivity could 
have disastrous consequences for the patients (Pera &van Tonder 2011:168). The 
PMTCT Option B+ will not be effective if patients are abused and not taken good care of 
by the nurses as some patients may even default the treatment given to them. 
 
Other participants’ perceptions with the care they receive from nurses include that they 
were not forced to start ART, but that the nurses let them decide and they even told 
them disadvantages of stopping the therapy. One participant said:  
 
“They were very understanding with me and they literally begged me to take 
medication.” (Participant 1). 
 
The respondents indicated that the nurses at this facility are in alignment with the 
UNAIDS 90-90-90 by 2020 campaign (getting to the zero world campaign) which is by 
2020: 
 
 90% of all people living with HIV will know their HIV status. 
 90% of all people with diagnosed HIV infection will receive sustained 
antiretroviral therapy. 
 90% of all people receiving antiretroviral therapy will have viral suppression 
(ICAP 2015:7; WHO 2016:2). 
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Sub-theme 3.2: Assistance in Health education about PMTCT Option B+ programme 
and effects of ART drugs 
 
The demographic data about level of education for the participants indicates that four 
participants had their primary education, seven had secondary education level and only 
six had completed their education. Lesser educational level means less health 
knowledge. A systematic review of health literacy and health outcomes found that 
individuals with lower health literacy had poorer health-related knowledge and 
comprehension, ability to demonstrate taking medications properly, and ability to 
interpret medication labels and health messages (Zimmerman 2015:1). The PMTCT 
nurses have an important role to ensure that pregnant mothers are more knowledgeable 
about the PMTCT programme so that they will be able to adhere to the demands of the 
programme. According to Bobb (2012:1), women must have access to education and 
knowledge as well as being empowered to protect them from HIV. 
 
Respondents showed some interest in knowledge of how they could protect their babies 
from being infected with the HI virus, and how to cope if their children got infected. Also 
participants needed to be encouraged on adherence. Participants responded by saying: 
 
“I need to be encouraged on taking the ARVs and also need knowledge on how 
to prevent my baby from being infected until I stop breast feeding him or her.” 
(Participant 2). 
 
“I need nurses to teach me on how to prevent my baby not to get HIV.” 
(Participant 6). 
 
“I need to be encouraged on continuous taking of treatment so that I can have a 
HIV negative baby.” (Participant 12). 
 
“I need nurses to always encourage me on taking the treatment properly so that 
my child can be prevented from HIV infection.” (Participant 14).  
 
“I need more information on preventing my child from being infected with HIV 
virus.” (Participant 16). 
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According to Corkery (2014:1), taking HIV treatment during pregnancy helps to reduce 
the risk of passing HIV to the baby. HIV treatment reduces viral load to HIV positive 
pregnant mothers so that the baby is exposed to less of the virus while in the womb and 
during birth. One of the factors that can increase the risk of passing HIV to baby is 
developing resistance to HIV treatment through not taking it properly as prescribed. It is 
important that health care workers emphasize on the importance of taking ARV 
treatment properly as prescribed so that the PMTCT programme will be effective. 
 
Some respondents showed some interest in knowing the side effects of the medication 
and side effects on long-term treatment of drugs, and when the treatment finished 
before the due date or any treatment if their ARV’s are finished.  
 
“I also need to know the side effects of long term treatment of HIV drugs.” 
(Participant 1). 
 
“I want to know if I have side effects like persistent rash, must I stop taking the 
tablets.” (Participant 6). 
 
“When the ARVs finished before the due date will my body be affected and if I am 
far away from this clinic can I go to the nearest clinic to get the 
ARVs?.”(Participant 9). 
 
“What are the side effects of ARVs and the life-long effects of the drugs in the 
body?” (Participant 11). 
 
“Want to know side effects of the drugs more especially if you do not adhere to 
treatment?” (Participant 13). 
 
The above responses are indicators that there is a great need of providing HIV positive 
mothers with information about side effects of ART treatment and management of these 
side effects. According to the Ministry of Health, Swaziland Government (2016:41), one 
of the negative influences to adherence is adverse events of treatment. Ebuy et al 
(2014:128) states that side effects of ART treatment are an obstacle to adherence. 
Another participant indicated that it was easier for her as she had prior knowledge about 
HIV testing; therefore health care workers must educate and encourage all pregnant 
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mothers to do an HIV test and encourage women of child bearing age to go for 
antenatal care as soon as they realise that they are pregnant.  
 
 
Sub-theme 3.3: Assistance in disclosure, adherence and ongoing counseling 
 
When participants were asked if they needed any assistance from nurses at the Public 
Health Unit, some responded that they needed assistance on how to disclose their 
status to their partners and family members as disclosure is one of the main challenges 
for most HIV positive pregnant women. Ebuy et al (2014:1) stated that disclosure of 
status to their partners affects HIV positive pregnant women adherence to the drugs. 
 
Some were quoted saying: 
  
“I need them to assist me on how to disclose my status to my partner and 
mother.” (Participant 1). 
 
“I need nurses to assist me on disclosing my status.” (Participant 11). 
 
The general perception by pregnant HIV positive women of routine counseling and 
testing as ‘compulsory’ also reinforces women’s acceptance of HIV. The perception that 
HIV testing was part of ANC routine and compulsory has also been documented in 
other African settings (Angotti, Dionne & Gaydosh 2011:1). Rajumba, Neema, Tumwine, 
Tylleskar & Heggenhougen (2013:19), also reported in their study on pregnant women’s 
experiences that routine HIV counselling and testing services were known and 
acceptable to mothers. 
 
The participants also responded that they need assistance with on-going counselling 
while on ART so that they will be able to adhere to treatment as they were quoted 
saying: 
 
“I still need on-going counselling so that I can be able to take treatment correctly 
and not stop taking the ARVs.” (Participant 3). 
 
“I need on-going counselling so that I can adhere to treatment.” (Participant 4). 
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“As I am taking ARVs for the first time during this pregnancy and I need nurses to 
continue counsel me on every visit so that I will be encouraged on taking ART.” 
(Participant 5). 
 
“I also need to be on-going counselling until I can be able to accept my status.” 
(Participant 11). 
 
Patients must be well-prepared for ART to avoid treatment failure, and it is 
recommended that all patients should participate in individual counselling sessions 
(Ministry of Health, Kingdom of Swaziland 2015:69). Adherence counselling and support 
should be provided during all patients encounters and key messages repeated regularly 
(Ministry of Health, Kingdom of Swaziland 2015:71). Indeed, for HIV infected women, 
PMTCT programme offer an ideal opportunity to link diagnostic and PMTCT services 
with on-going longitudinal care (Baylor International Paediatric AIDS Initiative 
2010:114). Other participants responded by saying they did not need any assistance at 
the moment because they thought they were taught everything they need to know: 
 
“The nurses taught me everything I needed to know.” (Participant 8). 
 
“The information that I was taught by the nurses was enough.” (Participant 7). 
 
“I do not know how they can help me because they provided me with enough 
knowledge on PMTCT.” (Participant 10). 
 
“At the moment there is no more information I need, maybe I will need some one 
day.” (Participant 12). 
 
These mothers also need to be assisted in meeting their health concerns and all their 
questions answered so that they will not be lost to follow. The patients’ active 
participation to establish treatment goals and the medical regimen is critical. To identify 
specific barriers to adherence the health care workers should identify and address any 
concerns about personal needs for ART, specific concerns about taking ART, and 
practical barriers to adherence (Ministry of Health, Kingdom of Swaziland 2015:71). 
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4.4.4 Theme 4: Effectiveness of the PMTCT Option B+ programme 
 
When participants were asked how effective was the PMTCT Option B+ programme, 
they responded by saying it was effective as it prolonged life span especially for those 
who adhere to treatment and take ART drugs at the same time everyday.  
 
Sub-theme 4.1: Prolongs life span 
 
The participants’ responses were as follows: 
 
“ARVs boost my immune, and prolong our lives, boost CD4 count and always 
help to stay healthier and not become ill.” (Participant 12). 
 
“It prolongs life for the mother and prevents HIV transmission to the baby.” 
(Participant 5). 
 
The participants’ responses concur with the Swaziland National AIDS Programme 
(2014:10), which states that the primary goal for ART is to achieve viral suppression 
and restore immunity (Increases the number of CD4 cells). It also states that clinical 
benefits of ART are to decrease opportunistic infections, maintain or reverse immune 
system damage and prolong survival. 
 
Sub-theme 4.2: Importance of adherence to treatment 
 
The findings in demographic history of participants also indicated that there were more 
numbers of unemployed participants with limited source of income and therefore, the 
issue of initiating in life-long ART may have impact on their lives as they will need 
money for transport to hospital visits for refill of medication. This is supported by the 
findings of a study conducted by Tweya, Gugsa, Hossenipour, Speight, Ngambi, 
Chikonda, Chauma, Khomin, Phosi, Mthande & Phiri (2014:136) in Lilongwe, Malawi, 
about understanding factors, outcomes, and reasons for loss to follow up among 
women in Option B+ PMTCT programme, which is lack of money for transport to travel 
to the facility as other contributing factor to ART discontinuation. This may affect the 
effectiveness of the programme if some HIV positive pregnant mothers may not return 
on the stipulated return date given at the hospital. 
Other participants responded as follows about the effectiveness of the programme: 
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            “I was sick at first coughing, sores and dizzy, but after taking the medication it was 
             gone and once taken and adherence practiced, you do not become sick.(Participant 2) 
 
“It is very effective, but mostly we want to start ART when we are sick and its 
effectiveness is compromised.” (Participant 3). 
 
“They say it is effective if you take the ART drugs every day at the same time.” 
(Participant 6). 
 
“You do not become sick if you adhere to the ART treatment.” (Participant 14). 
 
This statement indicates that the nurses had emphasized on adherence and 
importance of adherence as it is stated in the PMTCT guidelines that adherence 
for ART services includes the client taking the correct number of pills (correct 
dosing) at the correct frequency (Ministry of Health, Kingdom of Swaziland 
2015:88). Other respondent said that: 
 
            “I have been taking ARV’s for 6 months now and I still sometimes the head feels  
             dizzy especially if it is about to be the hour of taking my medication” (Participant 5). 
 
This indicates that there are side effects from the treatment and they create a 
barrier to adherence and even affect the success of the programme as other 
pregnant women may even stop taking the medication thus giving birth to HIV 
positive babies. Watson (2016:1), states that adherence is not easy because 
these drugs can cause side effects that can be severe enough to make some 
people stop taking them. Some side effects include nausea and vomiting, rash, 
appetite loss, diarrhea, fatigue, depression and anxiety, trouble sleeping and 
burning or pain in your hands. In the demographic history of testing children ten 
women had tested their children HIV status and a total of five respondents had 
their children tested HIV positive. This call for nurses to emphasise the 
importance of taking the treatment and some side effects may subside, and also 
encourage them to visit the health facility immediately if they encounter problems 
with medication than to stop taking them without consulting the nurses. 
 
Sub-theme 4.3: Prevention of mother-to-child transmission 
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Some participants responded by saying that the PMTCT programme is very 
effective as it protects the baby from being infected during pregnancy, delivery 
and breastfeeding as some of them were quoted saying: 
 
“It protects baby from getting infected.” (Participant 1). 
 
“It protects child during pregnancy so that my child will be born HIV negative.” 
(Participant 11). 
 
“Maybe, even my child will not be infected.” (Participant 12). 
 
“The child is protected from getting infected during delivery and breastfeeding.” 
(Participant 13). 
 
“If you take the medication correctly it protects the child during pregnancy, 
delivery and breastfeeding.” (Participant 14). 
 
“If you do not take them, it is easy to pass the HIV to the unborn baby.” 
(Participant 10). 
 
This is in contrast with the statement according to Hadebe (2012:13): “HIV can be 
transmitted from an infected mother to her child during pregnancy, labour and delivery, 
and breastfeeding”. Taking HIV treatment during pregnancy helps to reduce the risk of 
passing HIV to the baby (Corkery 2014:1). 
 
Although there are those who responded that they did not know the effectiveness of the 
programme as they were enrolled on the programme for the first time and they were 
taught about the programme and its importance. When asked about the effectiveness of 
the programme they responded by saying: 
 
“So far there is none, I will know once I tested my child and find that he or she is 
HIV negative.” (Participant 8).  
 
“I do not know because I am taking ART for the first time during this pregnancy.” 
(Participant 6). 
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According to Collins (2016:1), ART quickly reduces viral load, and ART start working 
from the first dose reducing viral load by 90% within the first few days. Some people 
take longer, especially if their viral load is very high when they start their treatment.  
 
4.4.5 Theme 5: Challenges of taking ARVs 
 
Even if this programme is good, there are challenges HIV positive pregnant mothers 
encounter when taking ARV’s. From the interviews in the testing history of the 
participants it emerged that 11 of the participants were tested HIV positive during this 
pregnancy, while six came for antenatal care services with known HIV status as one 
tested during hospitalisation and three of them tested because they wanted to know 
their HIV status. There was a great impact of starting PMTCT programme for the first 
time and also disclosing their HIV status to the partners. 
 
Sub-theme 5.1: Disclosure and Discrimination 
 
Some participants reported that they did not get support from their partners as they 
discriminated against them mostly after starting the medication. Others even left them 
as they did not want anything to do with them. Their partners even refused to do HIV 
test with them as a couple. They did not have only challenges to disclose to their 
partners, but also have challenges to disclose their status to their family members as 
others said they have a challenge to disclose their status to their parents or mothers.  
The following are some of the responses from HIV positive mothers who enrolled on 
PMTCT Option B+ programme about challenges they encounter: 
 
“I have known my status for 5 years now, but I have not disclosed my status to 
my husband because I am afraid he may leave me and my children.” (Participant 
2). 
“I have difficulty with disclosing my status to my partner, also of telling him that I 
am now taking ARVs.” (Participant 1). 
 
“It is real challenging when coming to disclosure, maybe I may disclose to my 
sister, but not to my parents and my partner.” (Participant 5). 
 
“I am afraid of disclosing my status to my family and friends.” (Participant 9). 
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“I have a challenge of disclosing my status to my partner and family members 
because they may not be able to accept my status. I even hide my tablets from 
them.” (Participant 11).  
 
These responses indicate that most HIV positive pregnant mothers have difficulty in 
disclosing their status to partners and family, and these may have a huge effect on 
adherence as for them to adhere to treatment they need support from their partners and 
families. HIV positive pregnant mothers need to be encouraged to disclose their HIV 
status to their partners and family members. One benefit of disclosure is to assist HIV 
infected individual in taking medication properly as she will be able to take medication 
openly and acknowledge her HIV status (Swaziland Ministry of Health 2014:35). 
 
Sub-theme 5.2: Partner testing 
 
Even though the nurses in the facility emphasize partner testing, they still have a 
challenge in this aspect as some other partners refuse to do HIV testing. As some 
participants responded by saying that: 
 
“My boyfriend even refuses to have sexual intercourse with me after I disclosed 
my status. I do not even know his status because he refuses to test together 
even though I told him that the nurses requested that we must do HIV test 
together.” (Participant 16). 
 
“I still had not disclosed my status to my partner even though I had known my 
status for five years. Every time when I visit the clinic the nurses encourage me to 
disclose my status, but my husband refused to come with me for testing.” 
(Participant 3). 
 
The Swaziland Government has to come up with some strategies on how to strengthen 
male involvement. For these programmes to be effective, HIV positive pregnant mothers 
need to take their medication regularly and openly. One participant responded that once 
they disclose their status their partners leave them. This also indicates that there are a 
number of male partners who still have fear of associating with an HIV positive partner. 
Even though the Swaziland Ministry of Health had been sensitizing the people of 
Swaziland on television, radios, heath facilities, community gatherings, rural kraal, 
schools etc., about HIV through health talks, pamphlets, drama, and advertisements; 
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but some people have not captured the message fully, while others are illiterate 
(Swaziland Government Ministry of Health 2015:9). According to Mahlalela (2016:16), 
the Swaziland government needs to work with men at the community level by properly 
consulting with them instead of common practice of talking to them since men are lively 
individualistic, make sure they use strategies that target men as well as mentor young 
men to become better and responsible adults in their roles as fathers and leaders in the 
community. The Swazi King, Mswati III demonstrated leadership by challenging men to 
get more involved and have responsibility to test and know their HIV status, to get 
treatment and to adhere to treatment (Mahlalela 2016:16)  
 
Sub-theme 5.3: Side effects of ART  
 
The other challenges reported were that some participants experience slight discomfort 
during the first few instances whilst taking the medication. This includes dizziness and 
swelling of the feet. Other respondents reported that they have a great challenge of 
taking medication even if they feel healthy and fit every day. Their responses were as 
follows: 
 
“I have a challenge of taking medication every day even when I do not have any 
pains.” (Participant 2). 
 
“Knowing that I have to take drugs every day even when I am not sick is a huge 
challenge for me.” (Participant 4). 
 
“…knowing that I will be taking medication for the rest of my life even when I am 
not ill is real stressing me sometimes.” (Participant 6).  
 
“The side effects of the drugs I am experiencing sometimes make me want to 
stop taking the medication. What make me continue taking them is that I want my 
child to be HIV negative.”(Participant 8). 
 
“When I started taking the tablets I experienced swelling of feet, but now I am 
fine.” (Participant 13). 
 
“When I started the treatment I had dizziness, maybe it was because my body 
was still adjusting to the medication.” (Participant 14) 
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These challenges may have a great impact on the effectiveness of the programme and 
may even result in some HIV positive pregnant mothers stopping taking the medication. 
There are those who were able to pass through the phases as they got support from 
their partners and family members. Below are some of the views they expressed:  
 
“I do not have any challenges because my family is supportive and my partner 
even went for HIV testing.” (Participant 10). 
 
“I had initially thought that I will fail to adhere to the time, but luckily I am 
reminded each time I had to take the medication.” (Participant 12). 
 
“None because I had disclosed to someone I trust, stigma is no longer an issue.” 
(Participant 17).   
 
The above responses indicated that with support from their partners and family 
members the HIV positive pregnant mothers were able to overcome all challenges they 
had as they took ART medication and that resulted in success of the PMTCT Option B+ 
programme and increase number of children testing HIV negative. According to the 
Ministry of Health, Swaziland Government (2016:41), positive influence to adherence to 
ART treatment includes support from family and friends, good relationship between 
patients and health care workers, and community 
 
4.5 CONCLUSION 
 
In this chapter, analysis, presentation and interpretation of the findings of the data 
collected from HIV positive pregnant mothers were accomplished. The findings of the 
study were presented in the sections of the demographic characteristics of the 
participants and personal perceptions of HIV positive pregnant mothers with regard to 
PMTCT Option B+ programme. The next chapter will present conclusions of the 
research study and the recommendations for future research 
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CHAPTER 5 
 
INTERPRETATIONS, CONCLUSIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
The purpose of the study was to investigate the perceptions of the HIV positive 
pregnant mothers regarding the PMTCT Option B+ programme at one public health unit 
in Swaziland. In this chapter, conclusions and recommendations based on the findings 
from the interviews with the participants are presented. 
 
5.2 SUMMARY OF THE FINDINGS OF THE STUDY 
 
This section presents the summary of the study based on the purpose and objectives. 
17 participants were interviewed about their perceptions regarding the PMTCT Option 
B+ programme. The researcher identified participants who were all HIV positive 
pregnant mothers and enrolled on PMTCT Option B+ programme by using their 
antenatal care cards. The researcher provided information about the study to HIV 
positive pregnant mothers who had enrolled on PMTCT Option B+ programme. The 
participants were informed that the study was voluntary for those willing to participate, 
and informed consent was obtained (Annexure E). Semi-structured interviews were 
conducted by the researcher and privacy was maintained (Annexure F). Participants 
who volunteered to take part in the study were given baby soap and a towel as 
incentives. 
 
The findings from the interviews conducted with the participants about the PMTCT 
Option B+ programme were presented in themes based on the objectives of the study 
which were to, explore and describe the perceptions of the HIV positive pregnant 
mothers with regards to PMTCT Option B+ programme, and also to make 
recommendations regarding the improvement of the PMTCT Option B+ programme in 
order to prevent the spread of HIV infection to babies. The demographic characteristics 
of the HIV positive pregnant mothers were related to age distribution, residential area, 
level of education, employment status, source of income, marital status, relationship 
status, living arrangements, pregnancy history, live births, testing of children and 
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participants’ testing history. The demographic characteristics of the participants were 
presented in the form of graphs, frequencies and percentages. The participants 
interviewed age group was between 18-39 years and the majority of the participants 
aged between 25-29 years. Regarding educational status, four had primary education, 
seven secondary education and six attained higher level of education. Most of the 
participants’ area of residence is more than eight kilometers from the Public Health Unit 
and in need of transport when coming to the facility. The majorities of the participants 
were unemployed with no source of income and married. 
 
5.3 INTERPRETATION OF THE RESEARCH FINDINGS 
 
In this section the results were interpreted based on the identified themes that emerged 
during data collection. The themes were: Perceptions of respondents on being enrolled 
on the PMTCT Option B+ programme, Understanding about PMTCT Option B+ 
programme and information needed with regard to PMTCT Option B+ programme, 
Perceptions with the care received from the nurses and their assistance on PMTCT 
Option B+ programme, Effectiveness of the PMTCT Option B+ programme, and 
Challenges of taking ARVs in a Public Health Unit in Manzini. 
 
5.3.1 Theme 1: Perceptions of respondents on being enrolled on the PMTCT 
Option B+ programme 
 
When participants were asked about their perceptions about being enrolled on the 
programme, they perceived this programme as preventing mother-to-child-transmission 
of HIV. Antiretroviral therapy helps to boost the HIV positive pregnant mothers’ immune 
system and prevent opportunistic infections so that they may not develop.  Their CD4 
count would then increase. The findings are strongly supported by M’edecins Sans 
Froniesres (MSF) (2013:1) who stated one of the benefits of PMTCT Option B+ 
programme as to increase maternal life expectancy, which means it allows HIV positive 
mothers to live longer by reducing the risk of opportunistic infections. Referring to the 
situation in Tanzania, Ngarina et al (2014:1) also mentioned this finding in a study 
conducted about women preferences regarding ARV prophylaxis for PMTCT of HIV and 
views on Option B+ programme, as an eagerness to prolong life through Option B+ 
programme. The participants thought that this would help them live a better and a 
longer life enabling them to raise their children for a much longer time before they die 
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(UNICEF 2012:20). Additionally, HIV can be transmitted from an HIV infected positive 
woman to her child during pregnancy, child birth and breast feeding.  MTCT accounts 
for over 90% of new HIV infections amongst children. Therefore, PMTCT Option B+ 
programme provides antiretroviral treatment to stop their infants from acquiring the 
virus. Without treatment, the likelihood of HIV passing from mother-to-child is 15% to 
45%. However, antiretroviral treatment and other effective PMTCT interventions can 
reduce the risk to below 5% (De Cock, Fowler, Mercier, deVincenzi, Saba, Hoff, 
Alnwick, Rogers & Shaffer 2000:3). 
 
5.3.2Theme 2: Understanding about PMTCT Option B+ programme and 
information needed with regard to PMTCT Option B+ programme  
 
The HIV positive pregnant women displayed a good knowledge and understanding of 
the PMTCT programme. The participants stated that PMTCT Option B+ programme is 
done during pregnancy, delivery and breastfeeding thus the treatment is taken to 
prevent mother-to-child transmission of HIV. Participants showed an understanding that 
they have an important role to play for the programme to be effective as they stated that 
it was important to take the ART drugs as prescribed. The participants stated that they 
took one tablet at a time, once every day, and for them to be effective they do not mix 
with some traditional herbs. Participants displayed good understanding of the fact that 
life-long ART is initiated immediately regardless of CD4 count and patients should start 
ART immediately when they are diagnosed with HIV. Once one started taking the ARVs 
one was expected to continue for the rest of your life. These findings indicated that the 
nurse midwives in the facility had provided health information to the HIV positive 
pregnant mothers. The participants’ response on the important role they have to play for 
the programme to be effective indicates that their high level of knowledge about PMTCT 
Option B+ programme will have a positive effect on the success of the programme. In 
addition, their awareness on the importance of taking ART medication as prescribed 
and not be mixed with traditional herbals is another good indication for success of the 
PMTCT Option B+ programme because many herbs and supplements contain 
undeclared pharmaceutical drugs, heavy metals and other contaminants, and practices 
such as mixing low doses of ARV drugs into herbal remedies would harm patients by 
leading to the development of viral resistance (Baylor International Paediatric AIDS 
Initiative 2010:304). Participants also understood that ARVs boost their immune system 
and prolong life.This result is consistent with research findings of the study conducted 
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by Ngarina et al (2014:1) in Tanzania about women preferences regarding ARV 
prophylaxis for PMTCT of HIV and views on Option B+ programme, which reported that 
the participants think that this programme will help them live a better and a longer life 
and enabling them to raise their children for a much longer time. The participants 
emphasised the importance of a balanced diet for ART treatment to be more effective, 
although it was a challenge for those HIV positive pregnant mothers who cannot afford 
proper diet or a meal. Good nutrition has the greatest impact at the early stages of HIV, 
strengthening the immune system to fight opportunistic infections (OIs) and delaying the 
progression of the disease. Good nutrition can play an important role in the care and 
management of HIV (Ministry of Health, Kingdom of Swaziland 2010b:109). 
 
Participants indicated that they needed knowledge about the PMTCT Option B+ 
programme. They responded that they needed to know about the side effects and long 
term effects of the ART drugs in the body; the importance of co-trimoxaxole drugs and 
different doses taken; and assistance on how to adhere to treatment. The nurses had a 
huge responsibility of providing the HIV positive pregnant mothers with on-going 
counselling so that they may adhere to treatment. In addition, nurses must be 
knowledgeable in order to be able to give information to the HIV positive pregnant 
mothers.  
 
5.3.3 Theme 3: Perceptions with the care received from the nurses and their 
assistance on PMTCT Option B+ programme 
 
The care the participants receive from the nurses at the facility is very satisfactory as 
expressed by the happiness in their responses. The nurses managed to build a good 
rapport with the HIV positive pregnant mothers. A good nurse-patient relationship will 
have a positive impact to the success of the programme because the HIV positive 
pregnant mothers will be willing to take any advises from the nurses about the PMTCT 
Option B+ programme. If all the nurses give such care to HIV positive women, the 
programme will be a great success. 
 
Disclosure of the HIV positive pregnant women status was one of the main challenges 
they have. As a result the participants requested assistance from the nurses on how to 
disclose their status to their husbands. This is supported by findings in the study about 
level of adherence and predictors of adherence to the Option B+ PMTCT programme in 
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Tigray, Northern Ethiopia conducted by Ebuy et al (2014:127). HIV positive women 
need proper counselling on advantages of adherence to the drugs and disclosure during 
drug provision. Some women responded that they needed assistance on side effects of 
the ART drugs and what they can do if they run out of their medication before the due 
date. There were those who feared that their babies may be infected by the HI virus and 
were concerned on what best they could do to avoid their babies being infected and 
how to cope if their babies are infected. On-going counselling was another concern for 
the HIV positive pregnant mothers, as for them to cope and accept their status they 
need on-going counselling and psychological care and support.  Adherence, counselling 
and support should be provided during all patients encounters, all their fears and 
concerns be addressed, and key messages repeated regularly so that these HIV 
positive pregnant women will adhere to ART treatment.  
 
5.3.4Theme 4:  Effectiveness of the PMTCT Option B+ programme 
 
When coming to the effectiveness of the PMTCT Option B+ programme the participants 
believed that it was very effective as it prolonged life span especially for those who 
adhere to treatment and take ART drugs everyday and at the same time. Other 
participants added that the PMTCT Option B+ programme is very effective as it protects 
the baby from being infected during pregnancy, delivery and breastfeeding. The 
outcomes of having a HIV negative baby can motivate the HIV positive pregnant women 
to adhere to the treatment and accept the programme. This finding is in contrast with 
findings of a study conducted by Thithi (2014:67) about perceptions of pregnant women 
on the PMTCT of HIV programme at the antenatal care unit and maternity ward at the 
Jordan Heynes community. The participants stated that they know that failure to adhere 
to treatment will lead to their babies having a great chance of testing HIV positive.  
 
5.3.5 Theme: 5 Challenges of taking ARVs 
 
Though the implementation of Option B+ programme has been aimed to decrease the 
number of HIV positive babies born, for some HIV positive pregnant women, there are 
challenges encountered with the programme when taking ARVs. Some participants 
reported that they encounter discrimination from their partners, no support from their 
partners once they initiate on ART, and others even leave them. Other challenges 
encountered include disclosure of their status to their partners and family members. 
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These challenges are barriers to the PMTCT Option B+ programme as they may have a 
huge effect on adherence to the ART treatment and retention to care. As a result 
pregnant women may refuse to do an HIV test for fear of discrimination and loss of their 
partners as some participants stated that once their partners know their HIV status they 
even leave them as they do not want anything to do with them anymore. A study by 
Kim, Zouh, Mazenga, Ahmed, Markham, Zomba, Simon, Kazembe & Abrams (2016:14) 
from Lilongwe, Malawi, reported that some participants needed time, whether it was for 
discussing their status with their partner or personally accepting their HIV status. For 
HIV positive pregnant women to adhere to treatment they need support from their 
partners and families. Another study conducted by Walcott, Hatches, Kwena & Turan 
(2013:8) in Kenya about facilitating HIV status disclosure for pregnant women and 
partners, participants reported that they struggled with the thought of how they would be 
viewed by the public after disclosing their status, and others reported that disclosure 
sometimes leads to violence from a male partner. The above results indicate that male 
involvement in HIV testing may facilitate adherence to ART treatment because it will be 
easy for pregnant women to disclose their status and will be more likely to accept ARV 
treatment. 
 
The other concern for HIV positive pregnant women was the early ART related side 
effects that can influence adherence to treatment, as the participants reported that they 
experienced discomfort during the first few instances while taking medication. These 
findings are supported by findings of a study conducted by Webb & Cullel (2013:15) in 
Uganda about Perceptions and experiences of people living with HIV regarding 
forthcoming Option B+ implementation. The participants raised concerns about PMTCT 
Option B+ in a study 15 which includes ARVs side effects, stigma when taking 
treatment, reluctant by male partners to use condoms and get tested. Others reported 
that it is really challenging taking medication whilst feeling healthy and fit every day. 
These challenges may have a great impact on the effectiveness of the programme and 
may even result in some HIV positive pregnant mothers stopping taking the medication 
thus leading to the higher risk of giving birth to HIV positive babies. Partner and family 
support is needed for them to be assisted in adherence to ART treatment. 
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5.4 CONCLUSIONS 
 
The implementation of PMTCT Option B+ in Swaziland will assist with the country’s goal 
to reduce the number of babies born HIV positive. In this study, perceptions of HIV 
positive pregnant women about PMTCT Option B+ programme indicated that the HIV 
positive pregnant mothers have knowledge about the programme. Furthermore, the 
nurses also played an important role of ensuring that HIV positive pregnant women 
were given enough information about the programme especially the benefits of it to 
them and their unborn babies. Good interpersonal relationship between nurses and HIV 
positive pregnant women will ensure the success of the programme. It is important to 
motivate the HIV positive pregnant women about the importance of the programme and 
offer on-going counselling to every antenatal visit to strengthen their knowledge about 
the programme. However, this study demonstrated that there are some challenges such 
non-disclosure and side effects of ART treatment that may affect adherence to ART 
treatment and loss to of HIV positive pregnant women. In that respect, the country’s 
goal will not be met. 
 
5.5 RECOMMENDATIONS OF THE STUDY 
 
5.5.1 Recommendations for practice 
 
The recommendations presented emerged from the research findings of the study as 
participants have a great challenge of disclosing their status to their partners and family 
members.  
 
 It is important that the Swaziland Government designs a strategy that will assist 
HIV positive pregnant mothers on facilitating disclosure of their HIV status to their 
partners. 
 The Swaziland Ministry of Health should develop male involvement strategies 
that will target both men in general, and men who are spouses of HIV positive 
pregnant mothers. According to the Swaziland Government Ministry of Health, 
(2015:14) men are important as they influence some women and others even 
make decisions for them, so involvement of men can increase PMTCT Option B+ 
programme uptake and adherence. Men need to be empowered with PMTCT 
Option B+ programme and male mentors and peer educators must be trained.  
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 The Swaziland Ministry of Health should develop an action plan that will promote 
partner testing and antenatal care attendance. There must be a strategy in place 
that will assist in tracking of HIV positive pregnant women and their partners and 
reinforce the need for partner testing. 
 It is also important that all men and women who are HIV positive must be linked 
to psychosocial support services, and that these systems must be available even 
in the rural areas. An explanation of side effects of ART drugs must be designed 
for use during pre-ART counselling of HIV positive pregnant mothers. 
 Good interpersonal relationships between nurses and HIV positive pregnant 
mothers should be reinforced by the Swaziland Ministry of Health. Nurses should 
have a good attitude towards HIV positive pregnant women because care 
received from health facilities will result in positive impact on the success of the 
programme. 
 
5.5.2 Recommendations for future research 
 
Deriving from the foregoing discussion, the following recommendations are presented: 
 
 The study was conducted in one facility in one region, thus only perceptions of 
HIV positive pregnant women regarding Option B+ programme of a small sample 
size in the country were studied.  However in order to know perceptions of other 
HIV positive pregnant mothers under the same context, it is the recommendation 
of the researcher for a similar study to be conducted in the other regions so as to 
allow generalisation of the results. 
 According to the research findings, HIV positive pregnant mothers who enrolled 
on PMTCT Option B+ face challenges of being discriminated against by their 
partners. A study of male involvement strategies must be conducted. The study 
will assist the Swaziland Ministry of Health to implement these strategies so that 
men can be able to understand the importance of PMTCT Option B+ programme, 
thus discrimination and stigma will be reduced. 
 Findings of the study indicated that most HIV positive pregnant mothers have 
difficulty in disclosing their status to partners and family, and these may have a 
huge effect on adherence as for them to adhere to treatment they need support 
from their partners and families. It is recommended that a study be conducted on 
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best strategies that can assist HIV positive pregnant mothers on how to disclose 
their status. 
 A study on perceptions of health care workers on PMTCT Option B+ programme 
is recommended and will help identify areas of improvement in the programme. 
 A study should be conducted at the health care facilities to investigate care 
received from nurses by HIV positive pregnant mothers who had enrolled on the 
PMTCT Option B+ programme. 
 
5.6 CONTRIBUTIONS OF THE STUDY 
 
The study investigated the perceptions of the HIV positive pregnant mothers regarding 
the PMTCT Option B+ programme. With Option B+ programme, most HIV positive 
pregnant mothers highlighted the effectiveness of life long ART therapy as it prolongs 
life span as long as they adhere to treatment, and also it prevents mother-to-child 
transmission of HIV and AIDS. Their knowledge will have a positive impact on the 
success of the programme as they are the key people who will spread the information to 
others and more HIV positive pregnant mothers will initiate on ART and adhere to 
treatment. The study highlighted the importance of on-going counselling; the heath care 
workers had to be encouraged to offer on-going counselling to the HIV positive pregnant 
mothers. 
 
It is important to emphasise good nurse patient relationship as more HIV positive 
pregnant mothers would adhere to treatment if the health care workers have a warm 
and welcoming reception at the heath care facilities. Also all HIV positive pregnant 
women concerns must be addressed especially the side effects of ART drugs. In the 
study the researcher found that partners support was repeatedly found to have a great 
influence on decision making for some women. Involvement of men can increase 
PMTCT Option B+ programme uptake and adherence. 
 
Specific challenges that may influence adherence to ART treatment were identified in 
the study. These challenges need to be addressed as they may have a negative impact 
on the effectiveness of PMTCT Option B+ programme and may even result in some HIV 
positive pregnant mothers stopping taking the medication. 
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The study also identified the importance of disclosure. Some participants indicated that 
they need assistance on how to disclose their status to their partners and family 
members as disclosure is one of the main challenge for most HIV positive pregnant 
mothers. Psychological care and support is another gap identified in the study. It is also 
important that all men and women who are HIV positive must be linked to psychosocial 
support services and these systems must be available even in the rural areas. 
 
5.7 LIMITATIONS OF THE STUDY 
 
 The study was conducted only at King Sobhuza Public Health Unit and the 
findings could not be generalised to the entire region. 
 The eligibility criteria was only HIV positive pregnant mothers who initiated ART 
during pregnancy, and those who were already on ART before pregnancy were 
not included, and therefore perceptions of all HIV positive pregnant mothers on 
ART were not investigated. 
 The possibility of sample bias was due to the fact that the study participants were 
only women living in semi urban setting that could not reflect experiences of HIV 
positive pregnant mothers from rural areas.  
 Finally, the study investigated perceptions of HIV positive pregnant mothers with 
regard to PMTCT Option B+ programme, and the most reasons for stopping ART 
were not investigated. 
 
5.8 CONCLUDING REMARKS 
 
In this chapter the researcher presented summary of findings, conclusions, 
recommendations, contribution of the study, and its limitations. With the initiation of 
PMTCT Option B+ programme, the Swaziland Ministry of Health had trained all health 
care workers about the programme so that it will be effective. However, the study 
demonstrated that there are some challenges that HIV positive pregnant mothers 
encountered that may affect the uptake and adherence to ART treatment and may 
result in failure of the programme. On-going counselling and support for HIV positive 
pregnant mothers encourage adherence and HIV negative babies will be born. 
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ANNEXURE A 
Ethical Clearance Certificate from the University of South Africa 
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ANNEXURE B 
Letter requesting permission from King Sobhuza Public Health Unit to conduct 
the research 
 
 
 PO BOX 5229 
                                                                                                             MANZINI 
                                                                                                             M200 
                                                                                                             7 September 2014 
 
KING SOBHUZA PUBLIC HEALTH UNIT 
P.O BOX 5229 
MANZINI 
Dear Madam 
REQUEST FOR PERMISSION TO CONDUCT A RESEARCH 
I hereby wish to request your permission to conduct a research study in your institution. 
I am currently registered with the University of South Africa for Master’s degree of 
Health Science. In order to fulfill the requirements of this Master’s I am required to 
conduct a research study. The research title is “PERCEPTIONS OF HUMAN 
IMMUNIODEFICIENCY VIRUS  POSITIVE PREGNANT MOTHERS REGARDING THE 
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION,OPTION B+ PROGRAMME 
IN A PUBLIC HEALTH UNIT IN MANZINI.” 
I will be conducting interviews with the clients who are enrolled on the prevention of 
mother-to-child transmission (PMTCT) Option B+ programme. I request that the 
interviews be tape recorded. However, I assure you that I will keep all information 
confidential and the anonymity of clients will be ensured by identifying them with codes 
instead of their names.  
Information gained will assist the Swaziland Ministry of Health and co-partners to see if 
there is efficiency and acceptability of the PMTCT Option B+ programme, and feedback 
of the study will be shared with you and the Ministry of Health. Permission to conduct 
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the study has already been obtained from the Swaziland Ministry of Health scientific and 
ethics committee. 
Should you require further information concerning the study contact my supervisor Dr. 
DSK Habedi at +27124296180. 
I hope to receive your approval to conduct the study. 
Yours faithfully 
Trusty Lomcebo Mbatha                                     Supervisor: Dr DSK. Habedi 
Cell: +268 78476183                                           Cell:+27124296180 
Email: lomcebot@gmail.com.                              Email:habeddsk@unisa.ac.za.  
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ANNEXURE C 
Letter seeking consent from Swaziland Ethical Committee, Swaziland Ministry of 
Health 
 
          P.O BOX 5229 
                                                                                                             MANZINI 
                                                                                                             M200 
                                                                                                             7 September 2014 
 
SCIENTIFIC AND ETHICS COMMITTEE 
SWAZILAND MINISTRY OF HEALTH 
P.O.BOX 5 
MBABANE 
Dear Sir/Madam 
REQUESTING FOR AN APPROVAL LETTER FOR PERMISSION TOCONDUCT A 
STUDY AT KING SOBHUZA PUBLIC HEALTH UNIT 
I hereby wish to request an approval letter for permission to conduct a study at King 
Sobhuza Public Health Unit. 
I am currently registered with the University of South Africa for Master’s of Health 
Science. In order to fulfill the requirements of this Master’s I am required to conduct a 
research study. The research title is “PERCEPTIONS OF HUMAN 
IMMUNIODEFICIENCY VIRUS  POSITIVE PREGNANT MOTHERS REGARDING THE 
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION, OPTION B+ PROGRAMME 
IN A PUBLIC HEALTH UNIT IN MANZINI.” 
I will be conducting interviews with the clients who had enrolled on the Prevention of 
Mother to Child Transmission (PMTCT) Option B+ programme. I request that the 
interview be tape recorded, however I assure you that I will keep all information 
confidential and atomicity of clients will be ensured by identifying them with codes 
instead of their names.  
Information gained will assist the Swaziland Ministry of Health and co-partners to see if 
there is efficiency and acceptability of the PMTCT Option B+ program, and feedback of 
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the study will be shared with your office and the Ministry of Health. Should you require 
further information concerning the study contact my supervisorDr DSK Habedi at 
+27124296180. 
I hope to receive an approval letter from the committee for permission to conduct the 
study. 
 
Yours faithfully 
Trusty Lomcebo Mbatha                                     Supervisor: Dr DSK. Habedi 
Cell: +268 78476183                                           Cell:+27124296180 
Email: lomcebot@gmail.com.                              Email:habeddsk@unisa.ac.za.  
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ANNEXURE D 
Ethical clearance letter from Swaziland Ethical Committee, Swaziland Ministry of 
Health 
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ANNEXURE E 
Informed consent form seeking consent from participants 
 
INFORMED CONSENT FORM (English) 
TITTLE OF STUDY: PERCEPTIONS OF HUMAN IMMUNIODEFICIENCY VIRUS  
POSITIVE PREGNANT MOTHERS REGARDING THE PREVENTION OF MOTHER-
TO-CHILD TRANSMISSION PROGRAMME , OPTION B+ PROGRAMME IN A PUBLIC 
HEALTH UNIT IN MANZINI.” 
NATURE AND PURPODE OF STUDY 
The purpose of the study is to investigate the perceptions of HIV positive pregnant 
mothers regarding Prevention of mother-to-child transmission of HIV Option B+ 
programme. 
There will be interviews of clients who have undergone the programme, their 
experiences, thoughts, and feelings about the programme. 
RESEARCH PROCESS  
Your participation in the study will be requested as you are a representative of the 
population under the study. You will be asked questions about the program and you are 
requested to be free when answering the questions. Please express all your opinions 
and these will be respected and valued. The interviews will be tape recorded and the 
interviewer will take notes during the interview. There will be privacy during the 
interview.   
CONFIDENTIALITY 
Privacy will be offered during data collection, and data will be kept confidential. Your 
identity will not be revealed since codes will be used instead of names. 
WITHDRAWAL CLAUSE 
Your participation is voluntary and you are free to withdraw anytime, and your 
withdrawal will not affect services to be offered to you at the facility. 
  
  
90 
WHAT IS THE POTENTIAL RISK? 
There will be no risk attached to your participation. 
POTENTIAL BENEFIT OF THE STUDY 
The study will assist the Ministry of Health in implementing the program and identify any 
hinders so that measures can be taken for the accomplishment of the program. 
AGE RESTRICTION 
For you to participate in the study you must be above 18 years of age. 
WHO TO CONTACT FOR MORE INFORMATION  
If you have any questions concerning the study or need more information about the 
study you can contact: 
Trusty Lomcebo Mbatha 
Cell: +268 78476183 
Email address:lomcebot@gmail.com   
CONSENT 
I, the undersigned (full name) have read the above information and I declare that I 
understand this information. I was given an opportunity to ask questions and was 
answered. I hereby declare that I agree voluntarily to participate in the study. 
I have received a signed copy of this consent form. 
Signature of participant: ………………………………………………… 
Signature of interviewer: ……………………………………………….. 
Signed at ………………………………….on ……………………           
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Consent form siSwati 
 
TITTLE OF STUDY: PERCEPTIONS OF HUMAN IMMUNODEFICIENCY VIRUS  
POSITIVE PREGNANT MOTHERS REGARDING THE PREVENTION OF MOTHER-
TO-CHILD TRANSMISSION OPTION B+ PROGRAMME IN A PUBLIC HEALTH UNIT 
IN MANZINI.” 
INHLOSO YALOLUCWANINGO 
Lolucwaningo lwentelwe kutsi fukundvwe kabanti ngabomake labaneligciwane le HIV 
labatfola kunakekelwa kulomtfolampilo ngekutsi bacabangani ngelusito labalutfola uma 
batetfwele noma sebabelekile.  
Bomake labanakekelwa kulomtfolampilo batocelwa kutsi bavete imicabango yabo 
ngeluhlelo labakulo lwekuvikela kutsi make atselele umntfwana ligciwane le HIV, 
ngemitsi labaniketwa yona ngesikhatsi batetfwele nanasebabelekile.  
Uyamenywa kutsi ube yincenye yalolucwaningo ngoba ungumake lotfola lusito 
lwekuvikela kutseleleka kwemntfwana ngeligciwane le HIV kulomtfolamphilo. Uma 
uvuma kubayincenye yalolucwaningo utawubutwa imibuto lemayelana nelusito lolutfole 
kulomtfolamphilo lwekuvikela kutseleleka kwemntfwana ngeligciwane leHIV kanye 
nemicabango yakho ngekunatsa amaphilisi eHIV nekuwanatsa ngendlela lengiyo. 
Uyacelwa kutsi ukhululeke nawuphendvula lemibuto, ukhulume imicabango yakho 
netifiso takho ngalolusito lolutfolako, konkhe lokushoko sitokuhlonipha siphindze 
sikulalele. 
Tingcogco letitawentiwa titobhalwa phansi emaphepheni phindze titsebulwe 
kubongcondvomshini, nalapho kutocociswana khona kutaba yindzawo lephephile 
ekukhulumisaneni imfihlo. 
KUGCINEKWA KWEMINININGWANE YAKHO IMFIHLO 
Uma uvuma kuba yincenye yalolucwaningo, timphendvulo takho titawugcinwa imfihlo. 
Libito lakho ngeke libhalwe kulamafomu alolucwaningo futsi angeke lisetjentiswe 
ndzawo kuchumanisa lositjele kona. Esikhundleni semabito sitosebentisa inombolo 
letsite lete budlelwane nelibito lakho. Kute lotawati kutsi nilungenele lolucwaningo. 
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NGINGAPHUMA YINI KULOLUCWANINGO? 
Unelilungelo lwekwenta sincumo sekuphuma kulolucwaningo nome nini, futsi angeke 
kutsibateke kusitakala kwakho kulomtfolamphilo. Utolitfola lonkhe lusito lolutele 
emtfolamphilo. 
YINI BUNGOTI BEKUNGENELA LUCWANINGO? 
Kute bungoti longabhekana nabo ngekungenela lolucwaningo. 
YINI INZUZO? 
Imininingwane yalolucwaningo litosita litiko letemphilo kutsi libone lokukhinyabeta 
kuphumelela kwaleluhlelo kute litotfutfukisa tinhlelo tekuvikela kutseleleka ngeligciwane 
kubantfwana 
IMINYAKA LEVUMELEKE KUNGENELA LOLUCWANINGO 
Kute ube yincenye yalolucwaningo kufanele kutsi ubeneminyaka lengetulu kwelishumi 
nesiphohlongo.  
NGUBANI LENGINGAMTSINTSA NANGABE NGINEMBUTO? 
Nangabe unembuto mayelana nalolucwaningo ungatsintsana na: 
Trusty Lomcebo Mbatha  
Lucingo: 78476183 
SIVUMELWANO 
Mine............................................................... (libito lwakho), sengifundzile lelifomu 
lwesivumelwano ngachazeleka, futsi ngiyavuma kutsi ngikuvisise konkhe lokubhalwe 
kulelifomu lwelucwaningo. Ngibenalo litfuba lwekubuta imibuto nami ngaphendvuleka 
emibutweni lenginayo. Ngakoke ngiyavuma kubayincenye yalolucwaningo. 
Nginikiwe lifomu lakami. 
Kusayina kwalongenele lucwaningo........................................................ 
Kusayina kwalowenta lucwaningo........................................................... 
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ANNEXURE F 
Data collection instrument: interview Questions 
 
PMTCT OPTION B+ PROGRAMME 
INTERVIEW GUIDE 
SECTION A 
INTERVIEW IDENTIFICATION 
PMTCT Client study identification number 
 
 
 
Date of interview 
 
 
 
Time of interview 
 
 
 
 
SECTION B 
BIOGRAPHIC DATA 
How old are you? 
 
Age: 
What is your area of residence? 
 
 
What is the highest level of education that 
you have completed? 
 
  Primary 
  Secondary 
  Higher 
  Did not attend 
 
Are you currently working? 
 
 
(a) If yes what type of work do you do? 
 
  Employed full-time 
  Employed part time 
  Employed seasonally 
  Informal job/hawker 
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  Attending school 
(b) What is the major source of income 
for your household? 
  Self employed 
  Full-time employment 
  Part-time employment 
  Informal employment 
  Pension 
  Social grant 
  Other: specify__________ 
  none 
Are you married    Yes 
  No 
Are you living together with your husband 
or you living together with your partner? 
 
  Yes, living with my husband 
  Yes, living with my partner 
  Husband or partner staying 
elsewhere 
Obstetric history: 
(a) How many times have you been 
pregnant? 
(b) How many children have you given 
birth to? 
(c) How many of these children are living? 
(d) Have you ever tested your children for 
HIV? 
 
(e) How many of your children have tested 
HIV positive? 
 
Number of pregnancies__________ 
 
Number of children__________ 
 
Number of living children________ 
  Yes, have tested my children 
  No, have not tested my children 
  Do not have children 
Number of children tested for HIV 
positive______ 
HIV testing history  
When did you first test HIV positive Year ______ 
Why was the test conducted   Tested during pregnancy 
  Tested during hospitalization 
  Wanted to know my HIV status 
  Other, specify___________ 
What is your religion?   A Christian 
  Not a Christian 
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SECTION C  
PERSONAL PERCEPTIONS AND EXPERIENCES WITH PMTCT OPTION B+ 
PROGRAMME  
1. What are your perceptions of being enrolled on the PMTCT Option B+ 
programme in King Sobhuza Public Health Unit? 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________ 
 
2. What do you understand about PMTCT Option B+ programme? 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
_______________________________________________________________ 
 
3. What is your perception with the care that you receive from the nurses at the 
facility? 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________ 
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4. How effective is the PMTCT Option B+ programme? 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
_______________________________________________________________ 
 
5. What challenges do you have of taking ARV treatment? 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
_______________________________________________________________ 
 
6. What information do you need with regard to PMTCT Option B+ programme? 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________ 
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7. How can the nurses in King Sobhuza Public Health Unit assist you as a HIV 
positive pregnant mother and enrolled on PMTCT Option B+ programme?). 
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________
________________________________________________________________ 
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PMTCT OPTION B+ PROGRAMME 
INTERVIEW GUIDE (SISWATI)   
 
SECTION A 
 
INTERVIEW IDENTIFICATION 
Inombolo 
 
 
 
Lusukulwelucwaningo 
 
 
 
Sikhatsi 
 
 
 
PMTCT OPTION B+ PROGRAMME 
INTERVIEW GUIDE (SISWATI)   
SECTION B 
BIOGRAPHIC DATA 
Uneminyakalemingakhi? 
 
Umnyaka______________________ 
Uhlala kuphi? 
 
Indzawoyekuhlala 
____________________________ 
Wafundza wafika kuliphi libanga 
 
  Libanga leliphasi 
  Libanga lelisekhatsini 
  Libanga leliphakeme 
  angifundzanga 
Umsebenti  
Ngabeuyasebenta yini? 
 
  Yebo 
  cha 
(a) ucashwe kanjani? 
 
  ucashwe sukhatsi lesidze 
  ucashwe sikhashana 
  ucashwe kusebenta ngetikhatsi letitsite 
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  uyatisebenta 
  uyafundza 
(b) Nguyiphi indlela lengenisa imali?   Ngiyatisebenta 
  Ngicashwe  
  Ngibamba imisetjentana 
  Ngitfola imali yembasha 
  Impenisheli  
  Lukunye_________________ 
  Kute 
 
Ngabe ushadile yini (ngesilungu nome 
ngesintfu) nome kukhona lovana naye?
 
  Yebo ngishadile 
  Yebo kukhona lengivana naye 
  Cha  
Ngabe wena nemyeni wakho nihlala 
ndzawonye noma yena uhlala 
encenye? 
 
  Sihlala ndzawonye 
  Uhlala encenye 
Ngabe sewake watitfwala kangakhi 
ubala nalokwamanje? 
 
 
Inombolo  yetisu_____________ 
Watala bantwana labangakhi? 
 
 
Bangakhi labaphilako? 
 
Inombolo yebantfwana_____________ 
 
 
Inombolo yebantfwana labaphilako 
_________________________ 
 
Bantfwana bakho sowake wabahlolela 
yini ligcgwiwane? 
  Yebo  
  Cha 
  Angati 
Bangakhi bantfwana bakho 
labatfolakala banaleligciwane le HIV?  
 
Inombolo yebantfwana labaneligciwane le 
HIV_______________________ 
 
 
Watfola nini kutsi uneligciwane le HIV? 
 
Umnyaka___________ 
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Wawulwentelani loluhlolo?   Wawutetfwele 
  Wahlola emvakwekulaliswa esibhedlela
  Wahlola emvakwekutfola unesifuba 
sengati 
  Ngangifuna kwati simo sami sengati 
  Lokunye______________________ 
 
 
SECTION C 
KUCONDZISISA NENDLELA LOBUKETA NGAYO EMAPHILISI EKUTSINTSIBETA 
LIGCIWANE LE HIV. 
1. Ngicocele, indzaba yekunatsa emaphilisi ekutsintsibeta ligciwane le HIV uyitsatsa 
njani wena? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
 
2. Yini lokwatiko ngalendlela lensha yekunatsa emaphilisi  ekutsintsibeta ligciwane le 
HIV kubomake labatetfwele? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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3. Wena ngekubona kwakho bukhona yini buhle bekunatsa emaphilisi ekutsintsibeta 
ligciwane le HIV? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
 
4. Uyikhandza injani indlela bonesi kulomtfolamphilo labanakekela ngayo tigulane 
letelashelwa ligciwane le HIV? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
5. Yini tingcinamba letibakhona ngekunatsa emaphilisi? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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6. Nguliphi lwati loludzingako mayelana nemaphilisi ekutsintsibeta ligciwane le HIV 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
 
7. Nguliphi lusito locabanga kutsi bonesi kulomtfolamphilo bangakusita ngalo 
njengamake lotetfwele nome loneluswane lonatsa lamaphilisi  ekutsintsibeta ligciwane 
le HIV? 
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________ 
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ANNEXURE G 
Editorial certificate 
 
 
 
 
 
 
In thy light 
Leseding la one 
EDITORIAL CERTIFICATE – LANGUAGE EDITING 
Perceptions of Human Immunodeficiency Virus Positive Pregnant Mothers 
Regarding the Prevention of Mother-to-child Transmision Programme in King 
Sobhuza Public Health Unit in Swaziland. 
By 
     Trusty Lomcebo Mbatha     
 
This serves to confirm that the above-named document has been edited  for language. 
Regarding the linguistic dimension, the following aspects were closely addressed : 
1. General orthographic aspects, including the discourse of research, that is, the 
extent to which research discourse is accurately applied. 
2. Spelling and punctuation, that is, the mainstay of communication.  
3. Attention was accorded to repetition and paragraphing. 
4. Tense usage in chapter contexts. Tense use is critical in terms of showing what 
has already been accomplished (past) ; what the researcher intends (future), and 
what is (present). The student is advised to revisit the entire dissertation to 
complement input from the Editor. 
5. Logical flow of argumentation, where close attention has been paid to coherence 
of thoughts and avoidance of disjointedness. 
cÜÉyA fA g|v{tÑÉÇwãt `ÉwxáàÉ  
DLitt et Phil (UNISA); MA-ESL (UZ); BEdCurr (UNISA); BA-Hons (Lond) DiP.Ed (UZ); DBM (INTEC); Cert.Law 
(UNISA) 
 
P.O. Box 978AAD 
[+267] 737 60 408 
ftds_enquiry@yahoo.com 
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6. Cohesion, which involves correct sequencing of parts of speech in order to 
communicate the intended messages in compliance with research problem and 
related questions. 
7. Syntax as it relates to clarity,  ambiguity and diction in sentences. Indications 
have been made to show that when the sentence is too complex, the intended 
meaning gets inevitably lost.  
The red in-text represents suggestions made to facilitate smooth and unambiguous 
flow, while the red in square brackets stands for suggestions to be considered by 
the author. There are situations when the editor is not sure what was intended by 
the researcher, so rectification is left to the candidate lest the editor distorts 
meaning. Where there is ambiguity, the author has been requested to revise a 
given section. 
 
Cancellations are made as suggestions to enhance both cohesion and coherence. 
It is noteworthy that all is left to the researcher’s discretion to factor in suggested 
changes, or not to do so. If in the researcher’s view the changes are unwarranted, 
the writer is at liberty to leave them as they are. 
 
        Prof. S. Tichapondwa Modesto (Dlitt et Phil) 
 

